P5 - Poster Session 5

Event Time:	Thursday May 9, 2019 11:30 am to 6:30 pm
Topic(s):	Practice, Policy, and Ethics, General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Movement Disorders, MS and CNS Inflammatory Disease, Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation
Director(s):
Description:
Completion Message:
CME Credits:	0
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
Currently there are no events in the timeline.

Disclosures
Speaker	Disclosure

Abstract Presenters
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	001	Undertreatment of Patients with Cluster Headache	Disclosure: Dr. Mannava has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	001	Effect of Leukoaraiosis on Decline in Naming in Primary Progressive Aphasia	Disclosure: Dr. Odolil has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	001	Longitudinal Measures of Radiographic Outcomes as Predictors of Clinical Disability in Multiple Sclerosis: A 12-Year Study	Disclosure: Dr. Feng has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	001	Out with the Old and In with the New - Understanding Barriers and Facilitators in Obtaining "New" Blood Pressure Goal for Patients with Ischemic Stroke	Disclosure: Dr. Sico has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	001	A novel TTN deletion causes Autosomal Dominant Limb-Girdle Muscular Dystrophy with Dilated Cardiomyopathy	Disclosure: Dr. Rich has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	001	Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome in an Open-label Extension Trial (GWPCARE5)	Disclosure: Dr. Patel has received research support from Greenwich Biosciences given to Nationwide Children's Hospital.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	001	Swallowing outcomes and discharge destinations in acute-stroke tube-feeding-dependent dysphagia patients treated with neuromuscular-electrical-stimulation during inpatient rehabilitation	Disclosure: Dr. Kushner has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	001	Medial temporal lobe subfield volumes are spared in non-amnestic Alzheimer's disease	Disclosure: Dr. Phillips has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	001	Striatal Acetylcholine and Dopamine are Necessary for Motor Function in Parkinsonism	Disclosure: Dr. Bamford has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	001	Utility of whole body 18-FDG-PET in management of Tuberculous Meningitis: A preliminary study from a tertiary care institute of North India	Disclosure: Dr. Modi has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	002	Acute Headache Diagnosis in the Emergency Department: Accuracy and Safety of an Artificial Intelligence System	Disclosure: Dr. Acosta has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	002	Anatomical Correlates of Verbal Fluency in Parkinson Disease	Disclosure: Dr. Rodriguez-Porcel has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	002	Dietary and Lifestyle Factors in Multiple Sclerosis Progression: Results from a 5-year Longitudinal MRI Study	Disclosure: Dr. Hagemeier has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	002	Blood Pressure at Hospital Arrival Does Not Reliably Distinguish Hypertensive Intracerebral Hemorrhage	Disclosure: Dr. Fakhri has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	002	Relationships between DMD mutations and neurodevelopment in dystrophinopathy	Disclosure: Dr. Thangarajh has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Avexis.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	002	Evaluation of Withdrawal Seizures During Conversion from Antiepileptic Drug Regimens Containing Carbamazepine to Eslicarbazepine Acetate Monotherapy	Disclosure: Dr. Ramsay has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB, Sunovion Pharmaceuticals Inc., Eisai, and Allied Group of Companies. Dr. Ramsay has received research support from Marinus, Sage, Sunovion Pharmaceuticals Inc., Eisai, and Lundbeck.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	002	Functional anomaly mapping using BOLD time-courses reveals local and distant dysfunction caused by stroke	Disclosure: Dr. DeMarco has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	002	Synergistic neuropathology resulting from co-expression of TDP-43 and tau protein in vivo	Disclosure: Dr. Moszczynski has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	002	L-Dopa-Induced Dyskinesias are Reduced by Propranolol in Parkinsonian Mice	Disclosure: Dr. Bamford has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	002	Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases detrimental Inflammation in Aged Mice with Bacterial Meningitis	Disclosure: Dr. Heide has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	003	Use of Traditional Medicine for Primary Headache Disorders in Kuwait.	Disclosure: Dr. Alshawaf has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	003	Network-Based Approach to the Role of the Inferior Frontal Gyrus in Word Retrieval and Selection	Disclosure: Dr. Mass has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	003	Vitamin D and Tobacco Use and Long-Term Clinical and MRI Outcomes among CIS patients: 11-year Follow-up of BENEFIT.	Disclosure: Dr. Martinez-Lapiscina has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with CIHR, Research Manitoba, Multiple Sclerosis Society of Canada, Multiple Sclerosis Scientific Foundation, Crohn’s and Colitis Canada, National Multiple Sclerosis Society, CMSC.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	003	Low and steady: Evidence for target blood pressure 24 hrs post-thrombectomy	Disclosure: Dr. Elangovan has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	003	NEO1 and NEO-EXT Studies: Long-Term Safety of Repeat Avalglucosidase Alfa Dosing for 4.5 Years in Patients With Late-Onset Pompe Disease	Disclosure: Dr. Dimachkie has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alnylam, Audentes, Biomarin, Catalyst, CSL-Behring, Genzyme, Mallinckrodt, Momenta, Novartis, NuFactor, Octapharma, RMS Medical, Sanofi, Shire and Terumo. Dr. Dimachkie has received research support from Alexion, Alnylam, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, CSL-Behring, FDA/OPD, GlaxoSmithKline, Genentech, Grifols, MDA, NIH, Novartis, Genzyme, Octapharma, UCB Biopharma, Viromed and TMA.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	003	Adherence to AED treatment for patients with focal seizure receiving monotherapy with eslicarbazepine acetate or prior generation generics: Evidence from a large US commercial claims database	Disclosure: Dr. Mehta has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sunovion Pharmaceuticals Inc.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	003	Causes of interruption of acute rehabilitation and readmission after stroke	Disclosure: Dr. Herrmann has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	003	Predicting Clinical Course in Persons with Mild Cognitive Impairment using structural MRI.	Disclosure: Dr. Ezzati has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	003	Glial alpha-synuclein induces a unique transcriptional program in vivo	Disclosure: Dr. Olsen has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	003	Nontraumatic Spontaneous Pneumocephalus in Clostridium Septicum Central Nervous System Infection – A Case Report	Disclosure: Dr. Karukote has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	004	Filling the Gap: CSF Fistula as a Presentation of Intracranial Hypertension	Disclosure: Dr. Szewka has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Contribution of Residual Anatomical Brain Networks in Language Recovery in Post-Stroke Aphasia	Disclosure: Dr. Kelkar has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	004	Adjusting neurofilament light levels using an MRI-based estimate of total axonal bulk improves its prediction of MS progression	Disclosure: Dr. Phillips has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	004	Sympathetic Nervous System Dysfunction Correlates with Increased Blood Pressure Variability after Acute Stroke	Disclosure: Dr. De Havenon has received research support from AMAG Pharmaceuticals and Regeneron Pharmaceuticals.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	004	GNE Myopathy Biomarkers: Essential for Diagnosis and Response to Therapy	Disclosure: Dr. Malicdan has received royalty, license fees, or contractual rights payments from Leadiant Biosciences. Dr. Malicdan has received research support from Leadiant Biosciences.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	004	Adjunctive Perampanel in Pediatric Patients with Epilepsy: Population Pharmacokinetic (PK) and Exposure-Response Analyses	Disclosure: Dr. Majid has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai Ltd.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Relationship of Neurologic Impairments to Post-Stroke Fatigue in an Urban, Minority Population	Disclosure: Dr. Yee has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	004	Preliminary neuropathological findings in porcine brains following hypobaric exposure	Disclosure: Dr. Cook has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	004	Over Expression of PERK Suppresses the Neurodegenerative Phenotypes in PINK1 Mutant Flies by Enhancing Mitochondrial Function	Disclosure: Dr. Cui has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	004	Acute Disseminated Streptococcus Anginosus Abscesses in a Young Immunocompetent Patient	Disclosure: Dr. Khalife has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	005	An Interdisciplinary Approach Between Neurology and Neurosurgery for the Treatment of Headaches in the Setting of Aqueductal Stenosis	Disclosure: Dr. Baker has nothing to disclose.
Behaviorial and Cognitive Neurology: Language, Memory, and Visuoperception II
Start Time	Pub.	Title	Presenter
11:30 AM	005	Impaired Global Network Topology in Residual Connectomes in Stroke-induced Aphasia	Disclosure: Dr. Medaglia has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	005	A History of Migraine Headache is Associated with Worse Disability and Walking Speed in a Cohort of Patients with MS	Disclosure: Dr. Damian has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	005	High In-Hospital Systolic Blood Pressure Variability and Poor Functional Outcomes in Primary Intracerebral Hemorrhage Patients	Disclosure: Dr. Alex has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	005	The IPANEMA Study: Top Line Results from an Investigator-Initiated Multi-site Late-onset Pompe Disease Prevalence Study	Disclosure: Dr. Wencel has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	005	Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an Open-Label Extension Trial	Disclosure: Dr. Halford has received personal compensation for consulting from GW Pharma and NCGS. Dr. Halford has received research support from Takeda, GW Pharma, SK Life Sciences, The Epilepsy Study Consortium, Brain Sentinel, and Philips.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	005	Repetitive Transcranial Magnetic Stimulation in Improving Lower Extremity Function and Gait Among Stroke Patients: A Meta-analysis	Disclosure: Dr. Matic has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	005	Connectomics in Brain Aging and Dementia	Disclosure: Dr. Chang has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	005	A kinome-wide Drosophila RNAi screen identifies glial adenylate kinases as modifiers of neuronal alpha-synuclein toxicity	Disclosure: Dr. Olsen has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	005	Listeria meningoencephalitis in an immunocompetent child	Disclosure: Dr. Kaul has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	006	Severity of Post-traumatic Headache in relation to Severity of TBI, PTSD and severe depression in Veterans of recent wars	Disclosure: Dr. Couch has received personal compensation in an editorial capacity for Springer.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	006	Greater Relative White Matter Burden is a Distinct Feature of Tauopathies in Frontotemporal Degeneration Spectrum	Disclosure: Dr. Giannini has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	006	Serum Neurofilament Light Chain and Glial Fibrillary Acid Protein in Patients With Multiple Sclerosis	Disclosure: Dr. Ayrignac has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	006	Blood Pressure Variability Post Mechanical Thrombectomy And Outcomes	Disclosure: Dr. Vu has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Novel Homozygous TNNT1 Missense Mutation in a French-Canadian Kindred Causing a Unique Clinical and Pathological Phenotype of Congenital Nemaline Myopathy with Rods, Cores and Lobulated Fibers	Disclosure: Dr. Pellerin has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	006	Efficacy and Tolerability of Adjunctive Brivaracetam in Adults With Focal Seizures by Antiepileptic Drug Treatment History: Post Hoc Analysis	Disclosure: Dr. Klein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Yes. Abbott: consultant; Alliance: medical advisory board; Acquestive: ad board; Eisai: consultant speaker; Lundbeck: research support; Sunovion: speaker; UCB Pharma: consultant, speaker.. Dr. Klein has received research support from Yes. Lundbeck.
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Pilot Study of Right Cerebellar tDCS as a Therapeutic Adjuvant in Chronic Aphasia after Left-Hemisphere Stroke	Disclosure: Dr. Dvorak has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Care Pathway for Post-Stroke Spatial Neglect: Initial Analysis of a Practice-Based Rehabilitation Research Network	Disclosure: Dr. Barrett has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with emedicine/WebMD. Dr. Barrett has received research support from Dart Neuroscience and Brightcloud International funded research projects she led through the Kessler Foundation.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	006	PBT434 Prevents a-synuclein Aggregation, Neuron Loss, Motor Dysfunction and Reduces Glial Cell Inclusions in a Transgenic Mouse Model of Multiple System Atrophy	Disclosure: Dr. Finkelstein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Prana Biotechnology. Dr. Finkelstein has received research support from Prana Biotechnology.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	006	Late-Onset Austrian Syndrome in a Patient with Bacterial Meningitis	Disclosure: Dr. Shapouran has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	007	One and Done: A Case Series of Large Volume Occipital Nerve Blocks for the Treatment of Occipital Neuralgia	Disclosure: Dr. Mathew has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Avanir, Teva, Biomobie staff, Amgen, Allergan, Promius, and Takeda.. Dr. Mathew has received personal compensation in an editorial capacity for Practical Neurology. Dr. Mathew has received research support from Biomobie.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	007	Plasma neurofilament light chain predicts disease progression in asymptomatic genetic frontotemporal dementia	Disclosure: Dr. Rojas -Martinez has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	007	The association between serum neurofilament light chain, atrophied lesion volume and brain atrophy with disability progression in multiple sclerosis	Disclosure: Dr. Tavazzi has nothing to disclose.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	007	Patients with Parenchymal Hemorrhagic Transformation and Poor Functional Outcome Have Distinct Systolic Blood Pressure Trajectories 72 hours After Mechanical Thrombectomy	Disclosure: Dr. Kodali has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	007	GNE Myopathy in Turkey: Clinical Features and Novel Mutations	Disclosure: Dr. Durmus has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	007	The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling	Disclosure: Dr. Nichol has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities as an employee of Greenwich Biosciences Inc..
Neuro-rehabilitation: Stroke Recovery
Start Time	Pub.	Title	Presenter
11:30 AM	007	Effect of Training Eye Hand Coordination Using Emerging Natural User Interface Technologies for Improving Hand Function in Stroke Survivors- A Randomized Controlled Study	Disclosure: Dr. Choudhary has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	007	Machine Learning of Quantified Volumetric MR Imaging for Diagnostic Delineation of Alzheimer’s Dementia and Mild Cognitive Impairment in the Alzheimer's Disease Neuroimaging Initiative	Disclosure: Dr. Raji has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brain reader.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	007	Dopaminergic Grafts Prevent Risk Of Secondary Parkinsonism In Cocaine Self-administering Rats	Disclosure: Dr. Venkiteswaran has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	007	Read Between the Lyme's: Case Series of Bannwarth Syndrome	Disclosure: Dr. Vu has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	008	Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report with Newly Described Electroencephalography (EEG) findings, Symptomatic Treatment Strategies, and Literature Review	Disclosure: Dr. Hooshmand has nothing to disclose.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	008	Progress and Participant Characterization in the Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) Rare Disease Clinical Research Consortium	Disclosure: Dr. Boxer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AbbVie, Asceneuron, Cellgene, Ipierian, Ionis, Janssen, Merck, Novartis, Toyama and UCB. Dr. Boxer holds stock and/or stock options in Alector and Aeton Therapeutics. Dr. Boxer has received research support from NIH, the Tau Consortium, the University of California Cures Alzheimer’s Disease program, the Bluefield Project to Cure FTD, Corticobasal Degeneration Solutions, and the following companies: Avid, Biogen, Bristol Myers Squibb, C2N Diagnostics, Cortice Biosciences, Eli Lilly, Forum Pharmaceuticals, Genentech, Roche and TauRx.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	008	HLA genotype as a marker of Multiple Sclerosis prognosis: results from a multicentric extension study	Disclosure: Dr. Lysandropoulos has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen Pharma.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	008	Examining the Mortality Benefit of Various Post Ischemic Stroke/TIA Hypertension Goals – an VA-based Observational Study	Disclosure: Dr. Sico has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	008	Long-Term Efficacy of Dichlorphenamide for the Treatment of Primary Periodic Paralysis (PPP)	Disclosure: Dr. Johnson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron, Strongbridge, Vertex, Fulcrum, and AveXis. Dr. Johnson has received personal compensation in an editorial capacity for Continuum. Dr. Johnson has received royalty, license fees, or contractual rights payments from University of Rochester. Dr. Johnson has received research support from Acceleron, CSL Behring, Fulcrum, Vertex, and AveXis.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	008	Perampanel in Real-World Clinical Care of Patients with Epilepsy: Retrospective Phase IV Study 506 – Second Interim Analysis	Disclosure: Dr. Wechsler has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with for Alexza, Eisai, GW Pharmaceuticals, Lundbeck, Sunovion, Cyberonics, UCB Pharma, UCB Pharma, and Upsher-Smith.Dr. Wechsler has received research support from Alexza, Eisai, GW Pharmaceuticals, Lundbeck, Marinus, Pfizer, SK Life Science, Sunovion, UCB Pharma, and Upsher-Smith.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	008	Action Observation Training Increases Dynamic Functional Connectivity in Patients with Multiple Sclerosis	Disclosure: Dr. Cordani has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	008	Creutzfeldt-Jakob Disease (CJD) Presenting as Epilepsia Partialis Continua: An Uncommon Presentation	Disclosure: Dr. Milani has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	008	Study of Yerba Mate (Ilex Paraguariensis) as a Neuroprotective Agent of Dopaminergic Neurons in an Animal Model of Parkinson's Disease	Disclosure: Dr. Tribbia has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	008	Microvessel Cerebral Vasculitis and Peripheral Neuropathy as Neurologic Manifestations in Rocky Mountain Spotted Fever	Disclosure: Dr. Danielson has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	009	Quality of life in patients with cluster headache during the active periods	Disclosure: Dr. Kim has nothing to disclose.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	009	Characteristics and Progress on 369 Subjects in the Longitudinal Evaluation Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol	Disclosure: Dr. Forsberg has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	009	No Association Between Lymphocyte Pharmacodynamics and Disability Following Alemtuzumab Treatment in Patients With Relapsing-Remitting Multiple Sclerosis	Disclosure: Dr. Meuth has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Almirall, Amicus Therapeutics Germany, Bayer, Biogen, Celgene, Chugai Pharma, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, QuintilesIMS, Roche, Sanofi-Aventis, and Teva. Dr. Meuth has received research support from Almirall, Amicus Therapeutics Germany, Bayer, Biogen, Celgene, Chugai Pharma, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, QuintilesIMS, Roche, Sanofi-Aventis, and Teva.
Blood Pressure and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	009	Admission Blood Pressure and Outcome after Successful Recanalization: a collaborative pooled analysis	Disclosure: Dr. Anadani has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	009	A Survey of Patient-Identified Symptom Themes and Attitudes Toward Clinical Trials in Facioscapulohumeral Muscular Dystrophy (FSHD)	Disclosure: Dr. Shirilla has received research support from Acceleron Pharma.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	009	Study 506 – Second Interim Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Pediatric Subgroup (Aged <12 Years)	Disclosure: Dr. Moretz has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	009	Remotely Supervised Transcranial Direct Current Stimulation (RS-tDCS) Paired with a Hand Exercise Program to Improve Manual Dexterity in Progressive Multiple Sclerosis: A Randomized Sham Controlled Trial	Disclosure: Dr. Feinberg has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	009	Young-onset Creutzfeldt-Jakob disease with neuropsychiatric presentation and prolonged disease course	Disclosure: Dr. Dhanapalaratnam has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	009	Exploring the role of the basal ganglia in the control and learning of motor sequences in mice	Disclosure: Dr. Riccelli has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	009	Eisenmenger Syndrome presenting as Focal Seizures	Disclosure: Dr. English has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	010	A Tale of two headaches – Use of Dynamic CT Myelogram to Localize Cerebrospinal Fluid Leak	Disclosure: Dr. Schachter has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	010	Cerebral venous thrombosis from thrombocytosis in a patient with thalassemia and splenectomy	Disclosure: Dr. Osman has nothing to disclose.
Frontotemporal Dementia II
Start Time	Pub.	Title	Presenter
11:30 AM	010	The Multidomain Impairment Rating (MIR) Scale: Initial Reliability Data on a Multidimensional Scale for FTLD	Disclosure: Dr. Boeve has received research support from Biogen and Alector.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	010	Predicting EDSS in MS through Imaging Biomarkers Using Artificial Neural Networks	Disclosure: Dr. Chaar has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	010	A novel frameshift mutation in DNA2 causes early onset myopathy with velopharyngeal weakness and cardiac arrhythmias	Disclosure: Dr. Gonzalez Del Angel has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	010	Comparative Neuropsychological Effects of Carbamazepine and Eslicarbazepine Acetate	Disclosure: Dr. Meador has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Epilepsy Study Consortium for Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. Dr. Meador has received research support from Sunovion.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	010	Clinical and fMRI Effects of Action Observation and Motor Imagery Training on Dual-Task Performances in Parkinson’s Disease Patients With Postural Instability and Gait Disorders	Disclosure: Dr. Sarasso has nothing to disclose.
Aging and Dementia/Behavioral and Cognitive Neurology ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	010	A case of Lymphomatosis Cerebri: a diagnostic challenge	Disclosure: Dr. Sheng has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	010	Progression of Parkinson’s Disease: A Longitudinal MRI Study of Functional Brain Connectome in a Large Cohort of Patients	Disclosure: Dr. Filippi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Merk-Serono, Novartis, Teva Pharmaceutical Industries. Dr. Filippi has received personal compensation in an editorial capacity for Journal of Neurology. Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries, Roche.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	010	A Rare Case of Mucormycosis Clivus Osteomyelitis Presenting With Stroke-Like Symptoms	Disclosure: Dr. Jacobson has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	011	Features of episodic cluster headache in the real world setting: clinical characteristics from a large, multi-national, cross-sectional survey	Disclosure: I am full-time employee and a stock shareholder of Eli Lilly and Company.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	011	Cerebral Venous Thrombosis In A Single Center Tertiary Hospital Of A South East Asian Country (CVSTS Study) – A Retrospective Study On The Clinical Profiles Of Patients with Cerebral Venous Thrombosis	Disclosure: Dr. Senga has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	011	Brain glucose metabolism in Lewy Body Dementia: implications for diagnostic criteria	Disclosure: Dr. CAMINITI has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	011	Loss of Brain Iron is Linked to Disability in Multiple Sclerosis - The Difference Between Concentration and Mass of Iron	Disclosure: Dr. Hagemeier has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	011	Carotid Artery Dissection in a Young Woman with Ullrich Congenital Muscular Dystrophy	Disclosure: Dr. Said-Said has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	011	Time Course of Efficacy and Tolerability Outcomes With Adjunctive Brivaracetam in Adults: A Post Hoc Analysis	Disclosure: Dr. Meador has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Epilepsy Study Consortium for Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. Dr. Meador has received research support from Sunovion.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	011	Interventional First-Person Video Game Training Reduces Fall Risk in Parkinson’s Disease by Improving Gait, Contrast Sensitivity, Visual Acuity and Cognition	Disclosure: Dr. Koul has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	011	Different Patterns of Brain Activity During Lower Limb Movements in Parkinson’s Disease Patients With and Without Freezing of Gait	Disclosure: Dr. Piramide has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	011	Cryptococcus Strikes Again: Recurrent Cryptococcal Meningitis in an Immunocompetent Host	Disclosure: Dr. McDermott has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	012	Trend of Cluster Headache Hospitalizations and their Associated Outcomes, a National Four Year Retrospective Review.	Disclosure: Dr. Chung has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	012	Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA.	Disclosure: Dr. Wells has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	012	18F-AV-1451 Tau Tracer Uptake Correlates with Medial Temporal Lobe Subregional Atrophy in Amyloid Negative Individuals	Disclosure: Dr. Das has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Rancho Biosciences.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	012	Unilateral Motor Progression in Multiple Sclerosis: Association with a Single Critical Corticospinal Tract Lesion	Disclosure: Dr. Sechi has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	012	The Potential Role of Estrogen in Moderating Symptom Severity in Women with RYR1-Related Myopathy	Disclosure: Dr. Sharp has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	012	Long-term Retention on Adjunctive Brivaracetam in Adults With Focal Seizures Previously Exposed to Carbamazepine, Lamotrigine, Levetiracetam, or Topiramate: A Post Hoc Analysis	Disclosure: Dr. Chung has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ucb, Sunovion, Lundbeck, Eisai. Dr. Chung has received research support from Ucb, SK Life Sciences.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	012	Motor Function of Individuals with HNRNPH2-related Disorders.	Disclosure: Dr. Salazar has received research support fromSMA Foundation, Biogen, Roche, AveXis, Mallinckrodt, Ultragenyx, PTC Therapeutics, Sarepta Therapeutics, and the Jain Foundation. .
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	012	Functional Network Connectivity Predicts Spreading of Cortical Atrophy in Parkinson’s Disease	Disclosure: Dr. Agosta has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	012	Comparison of Lumbar and Ventricular Cerebrospinal Fluid for Diagnosis and Monitoring of Meningitis	Disclosure: Dr. Kakadia has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	013	Intravenous Fosphenytoin as Rescue Treatment in Trigeminal Neuralgia Crisis	Disclosure: Dr. Schnell has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	013	Study of the factors predicting clinical outcome in patients with Cerebral Venous Sinus Thrombosis	Disclosure: Dr. Suhana has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	013	Abnormal neuropsychological memory testing and hippocampal volume in a clinical population.	Disclosure: Dr. Ruchinskas has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	013	The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis	Disclosure: Dr. Hemond has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	013	TTR Knockdown Therapy in Patients with hATTR Amyloidosis Who Have Disease Progression despite Liver Transplant	Disclosure: Dr. Moshe-Lilie has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	013	Experience with Eslicarbazepine Acetate Treatment at a Pediatric Epilepsy Center	Disclosure: Dr. Tanritanir has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	013	A Mixed-Methods Evaluation of Neurorehabilitation Resources for Pediatric Cerebral Malaria Survivors in Blantyre, Malawi	Disclosure: Dr. Boubour has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	013	Dual-Task in Parkinson’s Disease: A Gait Analysis and Functional MRI Study	Disclosure: Dr. Sarasso has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	013	Acute Chorea associated with Group C Streptococcus Pharyngitis	Disclosure: Dr. Zaribaf has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	014	Assessment and Management of Patients with Headache Referred to a General Neurology Consultation Service	Disclosure: Dr. Fearon has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	014	Cerebral Venous Thrombosis and Intracerebral Hemorrhage due to Pegaspargase Therapy for Acute Lymphoblastic Leukemia	Disclosure: Dr. Scarsella has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	014	Cholinergic-Related White Matter Lesion Load is Associated with Alzheimer’s Disease-Signature Cortical Thickness: The Northern Manhattan Study	Disclosure: Dr. Caunca has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	014	Oligoclonal band number as a predictor of multiple sclerosis disease course	Disclosure: Dr. Perrone has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	014	Lack of Genotype-Phenotype Correlation in Individuals with DMPK Expansions	Disclosure: Dr. Lindy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	014	Inpatient Hospitalization Risk in Medicaid Patients with Epilepsy Before and After Perampanel Treatment	Disclosure: Dr. Chatterjee has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai inc..
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	014	Restoration of Barnes maze, Protein Kinase M? and MAP2 by Minocycline plus N-Acetylcysteine when first dosed 72 hours after experimental traumatic brain injury	Disclosure: Dr. Rahman has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	014	Microstructure alterations in the midbrain of Parkinson’s patients: a multishell diffusion MRI study	Disclosure: Dr. Chen has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	014	A Case of Neurobrucellosis in a non-endemic area	Disclosure: Dr. Bronstein has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	015	Acute and preventive treatment patterns in episodic cluster headache: findings from the United States, United Kingdom and Germany	Disclosure: Dr. Nichols has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Nichols holds stock and/or stock options in Eli Lilly and Company which sponsored research in which Dr. Nichols was involved as an investigator. Dr. Nichols holds stock and/or stock options in Eli Lilly and Company.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	015	Reactive thrombocytosis related cerebral venous thrombosis: A rare complication of untreated iron deficiency anemia	Disclosure: Dr. Vaddiparti has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	015	Periventricular Cerebral Blood Flow as a Biomarker for Cerebral Small Vessel Disease	Disclosure: Dr. Dolui has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	015	Cognition as a Disability Progression Marker: Two-Years Follow-Up of People with Multiple Sclerosis	Disclosure: Dr. Motyl has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Sanogi Genzyme, Novartis.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	015	mRna Expression Genes Associated To Myofibrillar Myopathies – Preliminary Study	Disclosure: Dr. Carvalho has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	015	Efficacy and Tolerability of Switching from Traditional Sodium Channel Blockers to Lacosamide in Epilepsy Patients	Disclosure: Dr. Kim has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	015	The cofilin/Limk1 pathway controls the rate of regenerating motor axons	Disclosure: Dr. Da Silva has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	015	Impaired midbrain networks connectivity underlies freezing of gait in Parkinson’s disease	Disclosure: Dr. Droby has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	015	Immunomodulating Biologics and sCJD	Disclosure: Dr. Lee has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	016	Idiopathic Orbital Inflammation Presenting as Hemicrania Continua	Disclosure: Dr. Duvall has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	016	Clinical course of seizures in patients with cerebral venous thrombosis	Disclosure: Dr. Uygun has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	016	Associations Between Amyloid Burden, White Matter Hyperintensities and Cognition in Cognitively Normal Older Adults	Disclosure: Dr. Chapin has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	016	Baló Concentric Sclerosis: Benign Evolution in a Tunisian Population	Disclosure: Dr. Landolsi has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	016	Transition to Adulthood in Duchenne/Becker Muscular Dystrophy	Disclosure: Dr. Donaldson has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	016	Analysis of Patient Characteristics and Outcomes by Prior AED use: Data from Pooled Observational Studies of Routine Perampanel use across Europe	Disclosure: Dr. Trinka has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB, Eisai, Novartis, Gerrot-Lannach, BIAL, Takeda, Biogen, Newbridge, Sunovion. Dr. Trinka has received research support from Eisai Europe Ltd, GSK, Biogen-Idec, Novartis, Red Bull, Bayer, and UCB.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	016	Activity monitoring in neuromuscular disease: Successes, challenges, and a path forward	Disclosure: Dr. Lowes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AveXis, Inc., Bristol Meyers-Squibb, Pfizer, and Sarepta Therapeutics. Dr. Lowes has received research support from Novartis and Sarepta Therapeutics.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	016	Tracking Cortical Changes Throughout Cognitive Decline in Parkinson’s Disease: A Longitudinal MRI Study	Disclosure: Dr. Canu has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	016	Lyme Neuroborreliosis Initially Presenting as a Cavernous Sinus Syndrome: A Case Report	Disclosure: Dr. Rinehardt has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	017	Predictors of 30-Day Readmission Post Index Hospitalization for Cluster Headache: 5 Years National Estimate	Disclosure: Dr. Kim has nothing to disclose.
Cerebral Venous Sinus Thrombosis (CVST)
Start Time	Pub.	Title	Presenter
11:30 AM	017	Safety and Effectiveness of Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) in Patients with Concurrent Migraine Headaches and Focal Neurological Deficits.	Disclosure: Dr. Singh has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	017	Assessment of Deep Medullary Veins on 3T MRI in a Population-based Cohort	Disclosure: Dr. Ao has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	017	Serum GFAP Associates with Neurofilament Light and Disease Severity in Late Multiple Sclerosis	Disclosure: Dr. Airas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche, Merck . Dr. Airas has received research support from Sanofi-Genzyme.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	017	A Novel Case of Overlapping of Myotonic Dystrophy Type 2 and Bethlem Congenital Muscular Dystrophy	Disclosure: Dr. Chalia has nothing to disclose.
Epilepsy: Antiseizure Medications III
Start Time	Pub.	Title	Presenter
11:30 AM	017	Study 506 – Second Interim Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Adolescent Subgroup (Aged 12 to <18 Years)	Disclosure: Dr. Segal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai, Lundbeck, Nurticia, Novartis, Greenwich, Epitel, Encoded Therapeutics and Qbiomed.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	017	New treatments, now what: A pilot study investigating the use of in-home body-weight support harness systems to maximize the therapeutic benefit of novel treatments for spinal muscular atrophy.	Disclosure: Dr. Iammarino has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	017	Relationships Between Substantia Nigra Resting State Functional Connectivity and Uric Acid in REM Sleep Behavior Disorder and Parkinson’s Disease	Disclosure: Dr. Ellmore has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	017	Bartonella Papillitis Mimicking Anti-MOG Optic Neuritis	Disclosure: Dr. Sguigna has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	018	Accuracy of Pre-Headache Clinic SUNCT Diagnosis: A Cautionary Tale	Disclosure: Dr. Wax has nothing to disclose.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	018	Optical Properties and Oximetry Parameters of Cerebral Atrophic and Normal Regions in Healthy Volunteers	Disclosure: Dr. Roveri has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	018	Characterization of the Immunophenotype of Clinically Isolated Syndrome Patients Who Convert or Not To Multiple Sclerosis	Disclosure: Dr. Lee has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	018	Congestive Heart Failure is Strongly Associated with Hereditary Hemorrhagic Telangiectasia (HHT): Analysis of a Large National Database	Disclosure: Dr. Farooqui has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	018	X-Linked Myotubular Myopathy and Fragile X Syndrome in a Female Patient	Disclosure: Dr. Paul has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	018	Aura as a Predictor of Outcome after Epilepsy Surgery	Disclosure: Dr. Grossman has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	018	AbobotulinumtoxinA, onabotulinumtoxinA and incobotulinumtoxinA neurotoxin content and activity: Potential implications for duration of efficacy in patients	Disclosure: Dr. Field has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	018	Longitudinal Evolution of White Matter Damage in Parkinson’s Disease	Disclosure: Dr. Scamarcia has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	018	Diagnostic Challenge: Sporadic Creutzfeldt-Jakob Disease (sCJD) Presenting with Isolated Visual Symptoms	Disclosure: Dr. Morawo has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	019	Healthcare resource use and humanistic burden associated with attack frequency in episodic cluster headache	Disclosure: Dr. Andrews has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Andrews holds stock and/or stock options in Eli Lilly and Company which sponsored research in which Dr. Andrews was involved as an investigator. Dr. Andrews holds stock and/or stock options in Eli Lilly and Company.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	019	Cognition predicted by brain biomarkers and demographic factors	Disclosure: Dr. Tsapanou has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	019	Late onset MS is associated with more severe longitudinal development of central brain atrophy compared to adult onset MS	Disclosure: Dr. Dujmic has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	019	Life Expectancy in Familial Cerebral Cavernous Malformation: An Analysis of Prospective Database	Disclosure: Dr. Arsalan has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	019	PYGM mRNA Expression In Patients With McArdle Disease: Demographic, Clinical, Genetic And Morphological Correlations.	Disclosure: Dr. Feder has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	019	Long-term Outcomes in Patients with Intractable Mesial Temporal Lobe Epilepsy who Undergo Laser Ablation.	Disclosure: Dr. Patel has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	019	Burden of Spasticity Among Patients and Caregivers: Results of a Multinational Survey	Disclosure: Dr. Patel has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz and Allergan. Dr. Patel has received research support from Allergan, Merz, and Ipsen.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	019	Gray Matter Atrophy in Parkinson’s Disease and Freezing of Gait Assessed Using Surface-Based Algorithm	Disclosure: Dr. Kanovsky has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	019	Sarcoidosis to Nocardiosis: An odyssey of doubt and agony	Disclosure: Dr. Singh has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	020	Medical Cannabis Treatment in Patients with Trigeminal Neuralgia	Disclosure: Dr. Mechtler has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva, Promius, Allergan, Avanir, Amgen, Boston Biomedical, electroCore, Alder Biopharmaceuticals, Lilly. Dr. Mechtler has received research support from Dent Family Foundation.
Neuroimaging: Aging, Vascular and Other
Start Time	Pub.	Title	Presenter
11:30 AM	020	Increased Activity in Functional Brain Network among the Elderly with Youthful Memory in Superaging	Disclosure: Dr. Chun has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	020	Clinical Profile and functional outcomes of idiopathic inflammatory demyelinating disorders of CNS in adults.	Disclosure: Dr. Gorthi has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	020	Thyrotoxic Periodic Paralysis: An Unusual Presentation of Hyperthyroidism in a 20 year-old Male	Disclosure: Dr. Smith has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	020	Level Four Epilepsy Center Experience With Stereo-electroencephalography	Disclosure: Dr. Podkorytova has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	020	Economic evaluation of abobotulinumtoxinA vs onabotulinumtoxinA in real-life clinical management of post-stroke upper limb spasticity	Disclosure: Dr. Danchenko has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen Pharma.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	020	EEG-fNIRS Combined Neuroimaging Study on PD patients performing UPDRS Motor Tasks	Disclosure: Dr. Abtahi has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	020	Carbon Monoxide exposure, a red herring in a patient with rapidly progressive dementia, later diagnosed with Creutzfeldt-Jakob disease	Disclosure: Dr. Pang has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	021	Persistent Neurological Deficits in a Patient with Hemiplegic Migraine Revealing Diffuse Astrocytoma	Disclosure: Dr. Suneja has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	021	The Neural Substrate of Memory Impairment in the Oldest old with Dementia; The 90+ Study	Disclosure: Dr. Sajjadi has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	021	Real Life Evidence for CSF Neurofilaments Light Chain in Clinical Practice.	Disclosure: Dr. Carrillo-Loza has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	021	A Case of Dural A-V Fistula with Bilateral Thalamic Hyper-intensity	Disclosure: Dr. Komal Kumar has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	021	A NOVEL COMPOUND HETEROZYGOUS MUTATION IN TITIN LEADS TO CORE MYOPATHY WITH HEART DISEASE	Disclosure: Dr. Castoro has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	021	Altered resting-state network topology in drug-naïve idiopathic generalized epilepsy	Disclosure: Dr. Bin Kim has nothing to disclose.
Neuro-rehabilitation: From Mechanism to Treatment
Start Time	Pub.	Title	Presenter
11:30 AM	021	A study on Affordable Rehabilitation Care in Developing Countries with Use of Low Cost Technologies	Disclosure: Dr. Kokane has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	021	Initial Long-term Treatment with Rotigotine Maintains Striatal Dopamine Transporter Binding in De Novo Patients with Parkinson Disease	Disclosure: Dr. Ikeda has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	021	Aortic Fungus Ball – An Unusual Cause of Paraplegia	Disclosure: Dr. Natteru has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	022	Hypnic Headache: Characteristics and Treatment Modalities in An Academic Headache Center	Disclosure: Dr. Wax has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	022	Multimodal Magnetic Resonance Imaging versus 18F-FDG-PET to Identify Mild Cognitive Impairment	Disclosure: Dr. Dolui has nothing to disclose.
MS Metrics of Prognosis and Disease Progression
Start Time	Pub.	Title	Presenter
11:30 AM	022	Positive Predictive Value of Elevated Unique Cerebrospinal Fluid Oligoclonal Bands	Disclosure: Dr. Farin has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	022	Rapidly Progressive Cognitive Decline from a Dural AV Fistula	Disclosure: Dr. Berth has nothing to disclose.
Genetic Muscle Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	022	Diagnostic Challenges of Congenital Myopathies in the Adult Neuromuscular Clinic	Disclosure: Dr. Nicolau has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	022	Epilepsy MRI Interpretations Outside Of Comprehensive Epilepsy Centers Often Miss Epileptogenic Lesions	Disclosure: Dr. Ortiz-Guerrero has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	022	One Hundred Years of Innovation: Automatic Detection of Brain Ventricular Volume using Deep Learning in a Large-Scale Multi-Institutional Study	Disclosure: Dr. Han has nothing to disclose.
Parkinson's Disease: Animal Models and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	022	Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping	Disclosure: Dr. Huang has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	022	Leprosy presenting as orofacial pain: case report.	Disclosure: Dr. Macedo has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	023	Sex-induced Headache Associated with Moyamoya Angiopathy: A Case Story and Literature Review	Disclosure: Dr. Chen has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	023	Clinical and Molecular PET Imaging Markers of Primary Progressive Aphasia due to Likely Alzheimer's Disease Pathology	Disclosure: Dr. Roll has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	023	Sex-specific Differences in Rim Appearance of Multiple Sclerosis Lesions on Quantitative Susceptibility Mapping	Disclosure: Dr. Tolaymat has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	023	Clinical and Radiographic Features of Multiple Intracranial Arteriovenous Malformations	Disclosure: Dr. Chiu has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	023	Incidence and Predictors of readmission in patients with Myasthenia Gravis: A National population-based cohort study (2010-14).	Disclosure: Dr. Singh has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	023	Epilepsy Surgery Outcomes in the setting of Encephalitis: A Case Series	Disclosure: Dr. Spurgeon has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	023	Abnormal DWI Signals of Spine in a Sporadic Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia caused by a novel c.1907T>A. Mutation in CSF1R	Disclosure: Dr. Li has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	023	Barriers and Characteristics of Caregiving Preparedness in Parkinson’s disease: a qualitative approach	Disclosure: Dr. Nwadiogbu has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	023	The Mysterious Mold: A Case of Coccidioides Meningitis	Disclosure: Dr. Slawski has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	024	Diagnostic Delay in Patients Prior to Being Seen in Headache Clinic	Disclosure: Dr. Puvvadi has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	024	The Relationship of Amyloid Beta in the Retina to that of the Brain is Burden-specific	Disclosure: Dr. Bissig has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	024	Demyelination, Inflammation and Axonal Loss Explain Different Patterns of Fractional Anisotropy Abnormalities in MS Cortical Normal Appearing Gray Matter and Lesions	Disclosure: Dr. Preziosa has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Novartis and ExceMED.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	024	Is There Any Pivotal Association Between Smoking and Alpha-1 Antitrypsin Level and Function in Aneurysmal Subarachnoid Hemorrhage?	Disclosure: Dr. Ansari has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	024	LEMS with Anti-VGCC Antibodies and Dermatomyositis with Anti-TIF1-Gamma Antibodies: A Unique Case Study of Concomitant Autoimmune Neuromuscular Conditions without Malignancy	Disclosure: Dr. Isfort has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	024	Hospital Readmissions After an Epilepsy Related Surgical Intervention in the Nationwide Readmissions Database	Disclosure: Dr. Subramaniam has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	024	Clinical and Radiographic Characterization of Synthetic Cannabinoid-induced Toxic Leukoencephalopathy	Disclosure: Dr. Amar has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	024	What Bothers Parkinson Patients: Clinical Curation of their Verbatim Reports	Disclosure: Dr. Arbatti has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Grey Matter Technologies.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	024	Unilateral Periorbital and Facial Swelling with Multiple Unilateral Cranial Nerve Deficits in an Uncontrolled Diabetic	Disclosure: Dr. Dicken has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	025	One-Month Feasibility of Progressive Muscle Relaxation (PMR) via Smartphone Application for Post Traumatic Headache (PTH) Patients	Disclosure: Dr. Usmani has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	025	Diffusion Tensor Imaging in pre-dementia risk states: white matter atrophy findings in Mild Behavioral Impairment	Disclosure: Dr. Gill has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	025	3D MR image synthesis using unsupervised deep learning algorithm in MS patients	Disclosure: Dr. Jabarzedeh has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	025	Dynamic Cerebral Autoregulation and Personalized Blood Pressure Monitoring in Patients with Aneurysmal Subarachnoid Hemorrhage (aSAH)	Disclosure: Dr. Silverman has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	025	Response Rates in Placebo arm of MG Clinical Trials	Disclosure: Dr. Muppidi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion Pharmaceuticals.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	025	Epilepsy Surgery Trends In the United States, 2009–2014	Disclosure: Dr. Vellipuram has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	025	Cocaine Use Associated with Bilateral Globus Pallidus Changes; Similar to Carbon Monoxide intoxication.	Disclosure: Dr. Azeem has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	025	A Closer Look at the Unmet Needs, Research and Care Priorities for Women with Parkinson's	Disclosure: Dr. Feeney has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	025	Community-acquired Klebsiella pneumoniae meningitis. Questioning the demographic paradigm with new recommendations for diagnosis and effective treatment	Disclosure: Dr. Michaelson has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	026	Marijuana Use In Headache In a University–Based Headache Clinic	Disclosure: Dr. Schorn has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	026	Phenotypes and Biomarkers in Posterior Cortical Atrophy: Application of Consensus Clinical Diagnostic Criteria and the AT(N) Framework	Disclosure: Dr. McGinnis has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	026	A comparison of FLAIR and T1 maps from MP2RAGE at 7T for quantifying lesion volume and its correlation to disability in multiple sclerosis	Disclosure: Dr. Spini has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	026	Endovascular Therapy Versus Clipping For Aneurysmal Subarachnoid Hemorrhage, 2004-2014 Trends	Disclosure: Dr. Venkatraman has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	026	Congenital Myasthenic Syndrome with A Novel Agrin Gene Mutation	Disclosure: Dr. Giler has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	026	Contralateral hippocampal atrophy after temporal lobe surgery: volumetric analysis of preoperative and long-term postoperative MRI	Disclosure: Dr. Silva has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	026	Capecitabine Induced Leukoencephalopathy: Is there a correlation with liver metastases?	Disclosure: Dr. Ibrahim has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	026	SNCA G51D Missense Mutation Causing Juvenile Onset Parkinson’s Disease	Disclosure: Dr. Cooper has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	026	Pituitary Apoplexy Mimicking Meningoencephalitis: A Case Report and Literature Review	Disclosure: Dr. Chu has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	027	A Survey Comparing Neurology and Internal Medicine Residents’ Approaches to Headache Management	Disclosure: Dr. Cooper has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	027	Correlates between functional connectivity and amyloid deposition in healthy controls	Disclosure: Dr. Bruña has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brainvestigations.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	027	New/Enlarging Lesion Count: Man versus Machine	Disclosure: Dr. Van Hecke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with icometrix.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	027	Early Elevation of Plasma Lipocalin-2/NGAL is Associated with Poor Neurofunctional Outcome in Subarachnoid Hemorrhage Patients	Disclosure: Dr. Yu has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	027	The Diagnostic Yield of Repetitive Nerve Stimulation in Seropositive vs. Seronegative	Disclosure: Dr. Hua has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	027	The Pathogenesis and A Novel Surgical Approach to Treating Drug-Resistant Status Epilepticus Associated with Neurocysticercosis	Disclosure: Dr. Law has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	027	Tacrolimus Induced Osmotic Demyelination in Patient with Liver Transplantation	Disclosure: Dr. Pauta Martinez has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	027	Levodopa Responsiveness Subtypes of Freezing of Gait: Results Using a Levodopa Test	Disclosure: Dr. Factor has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Neurocrine, Lundbeck, Teva, Avanir, Sunovion, Adamas, Prexton, Biogen. Dr. Factor has received research support from Ipsen, Medtronics, Teva, US World Meds, Sunovion, Solstice, Vaccinex, Voyager, CHDI Foundation, Michael J. Fox Foundation, NIH.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	027	Suboxone abuse with shared needle as a cause of Botulism in an IV drug user	Disclosure: Dr. Roy has nothing to disclose.
Headache
Start Time	Pub.	Title	Presenter
11:30 AM	028	Undertreatment of Headache Associated with Sexual Activity	Disclosure: Dr. Cuneo has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	028	Association of Cortical and Subcortical Aß Deposition with Depressive and Anxiety Symptoms: A Population-based Cross-sectional Study	Disclosure: Dr. Krell-Roesch has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	028	Correlation Between Neurologic Challenge Task Performance and Lesion Localization of Sub-Threshold Lesions in Multiple Sclerosis Patients with EDSS Score of 0	Disclosure: Dr. Antoine has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	028	Novel explanation of angular remodeling in stent assisted coiling (SAC) of bifurcation aneurysms: Is it the stent or the coils?	Disclosure: Dr. Saied has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	028	Efficacy and limitations of cyclophosphamide in refractory myasthenia gravis	Disclosure: Dr. Garcia Trejo has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	028	VNS therapy vs. discontinuation of VNS therapy: Long-term seizure outcome	Disclosure: Dr. Gill has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	028	Is Acute Immunodeficiency Syndrome (AIDS) a risk factor for Central Pontine Myelinolysis (CPM).	Disclosure: Dr. Zeb has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	028	Altered Dopamine Transmission in Peripheral Mononuclear Cells in Parkinson's Disease	Disclosure: Dr. Saadatpour has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	028	Lyme disease presenting as multiple small cerebral infarcts of undetermined source.	Disclosure: Dr. Alcantara Lima has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	029	Functional brain connectome organization associated with atrophy and hypometabolism in posterior cortical atrophy	Disclosure: Dr. Migliaccio has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	029	Automatically segmented medulla oblongata volume as a surrogate for spinal cord atrophy in multiple sclerosis	Disclosure: Dr. Bergsland has nothing to disclose.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	029	Systematic Review of the Angiographic Evoluation of Neck Residual (Class II) Aneurysms	Disclosure: Dr. Maud has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	029	Assessment of disease severity in patients with Myasthenia Gravis – Clinical Phenotype and Immunological Correlation	Disclosure: Dr. Garuda has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	029	Patient selection and outcomes of placement of the Neuropace Responsive Neurostimulator for the treatment of intractable epilepsy: a single center experience	Disclosure: Dr. Agostini has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	029	Post-Mortem Neuroimaging in Amyotrophic Lateral Sclerosis	Disclosure: Dr. Ishaque has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	029	Incidence and Predictors of 30 days readmission associated with Parkinson’s disease: 5-year National estimate (2010-2014)	Disclosure: Dr. Singh has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	029	Sudden Death from Rupture of Cerebral Abscess into Subarachnoid Space	Disclosure: Dr. Curran has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	030	Tracking Neurostructural Preclinical Predictors of Alzheimer’s Disease: Linking Clinical Markers to the Size of the Ventral Tegmental Area and Other Subcortical Nuclei	Disclosure: Dr. De Marco has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	030	Inflammatory activity associated with increased rate of brain and retinal neuro-axonal injury in early MS The aim of this study is to address the effect of local inflammatory activity in brain and retinal neuro-axonal injury along MS course.	Disclosure: Dr. Pulido Valdeolivas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche Spain, Genzyme-Sanofi, and Aura Innovative Robotics. Dr. Pulido Valdeolivas has received compensation for serving on the Board of Directors of Aura Innovative Robotics. Dr. Pulido Valdeolivas has received royalty, license fees, or contractual rights payments from Aura Innovative Robotics. Dr. Pulido Valdeolivas holds stock and/or stock options in Aura Innovative Robotics which sponsored research in which Dr. Pulido Valdeolivas was involved as an investigator. Dr. Pulido Valdeolivas holds stock and/or stock options in Aura Innovative Robotics. Dr. Pulido Valdeolivas has received research support from Aura Innovative Robotics.
Intracerebral Aneursym and Other Neurovascular Malformations
Start Time	Pub.	Title	Presenter
11:30 AM	030	Impact of daughter vessel selection for stent deployment on the recanalization rates of bifurcation aneurysms treated with single stent-assisted coiling (SAC)	Disclosure: Dr. Saied has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	030	Are the choices of Therapeutic options for the Management of Myasthenia Gravis Crisis with acute respiratory failure-Influenced by the patient’s Age. A New York State Planning and Research Cooperation System Database Analysis (1998-2014)	Disclosure: Dr. Sheikh has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	030	Effects of Low- Frequency Stimulation of Anterior Piriform Cortex on Memory in Epileptic Rats	Disclosure: Dr. Bayat has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	030	Evolution of Magnetic Resonance Signal Characteristics in Inferior Olivary Nuclei in Patients Presenting with Palatal Myoclonus Syndrome – Cases	Disclosure: Dr. Manering has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	030	G2019S mutation and motor complications of levodopa in Parkinson disease	Disclosure: Dr. Farhat has nothing to disclose.
Bacteria, Fungi, and Prions
Start Time	Pub.	Title	Presenter
11:30 AM	030	Paradoxical reaction in non-HIV patients with CNS tuberculosis: what, when and how?	Disclosure: Dr. Dominguez-Moreno has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	031	Location of Intracerebral Hemorrhage and Cause of Death in the Longitudinal Follow-up of ICH Survivors in ERICH (ERICH-L) Study	Disclosure: Dr. Bakk has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	031	WMH Progression but not Regression is Associated with a Higher CSF tau/Aß and Temporal Amyloid Concentration in The Amyloid PET Scan	Disclosure: Dr. Al-Janabi has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	031	Investigation into the Relationship between Digital Brain Volume and Computerized Screening Assessment of Cognitive Function in People with Multiple Sclerosis: Objective Analytics to Quantify Disease Impact – Cross Sectional Relationship	Disclosure: Dr. Srinivasan has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	031	A case of hepatocellular carcinoma presenting with myasthenia gravis	Disclosure: Dr. Fussner has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	031	Evaluating an Online Tool to Determine Appropriateness for Epilepsy Surgery Evaluation in Brazil	Disclosure: Dr. Bianchin has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	031	Magnetic Resonance Imaging-Based Evaluation of the Etiology of Non-traumatic Myelopathies in Bangladesh: A Hospital-based Observational Cross-sectional Study from Two Tertiary Care Centers of Dhaka.	Disclosure: Dr. Shoab has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	031	Changes in Prescribing Practices of Dopaminergic Medications in Individuals with Parkinson's Disease by Expert Care Centers From 2010 to 2017: The Parkinson's Foundation Quality Improvement Initiative (PF-QII)	Disclosure: Dr. Dubaz has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	031	Intramedullary spinal neurocysticercosis	Disclosure: Dr. Manske has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	032	Predictors and Associated Outcomes with Unanticipated Surgical Evacuation in Patients with Intracerebral Hemorrhage: Post Hoc Analysis of ATACH 2 Trial	Disclosure: Dr. Qureshi has nothing to disclose.
Neuroimaging: Alzheimer Disease
Start Time	Pub.	Title	Presenter
11:30 AM	032	Structural Brain Organization Associated with Gait in Mild Cognitive Impairment Subtypes	Disclosure: Dr. Allali has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	032	Quantitative Spinal Cord MRI in MS patients with Sexual Dysfunction: A Cross-sectional Study.	Disclosure: Dr. Seyman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen-Idec. Dr. Seyman has received research support from Novartis.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	032	Myasthenia Gravis Mimicking Stroke - Implications of Cognitive Errors and Clinical Factors	Disclosure: Dr. Kukulka has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	032	Early Use of Vagal Nerve Stimulation (VNS) in a Patient with New Onset Refractory Status Epilepticus (NORSE)	Disclosure: Dr. Wong has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	032	Diagnostic utility of hypoglossal canal MRI in uncovering an unusual cause of Isolated hypoglossal nerve palsy.	Disclosure: Dr. Rayi has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	032	Survival in Parkinson disease, the Trondheim cohort	Disclosure: Dr. Hustad has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	032	Neurocysticercosis in Qatar	Disclosure: Dr. Shaheen has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	033	In-hospital Mortality, Resource Utilization and 30-Day Readmission among Patients with Intracerebral Hemorrhage Transferred to Centers with Higher Level of Care	Disclosure: Dr. Bambhoroliya has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	033	Clinical and Conventional MRI Predictors of Cognitive Rehabilitation Efficacy in Multiple Sclerosis	Disclosure: Dr. Fuchs has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	033	High Prevelance Of Osteoporosis And Osteopenia In Adult Myasthenia Gravis Patients-A Pilot Study From An Academic Institution In Central Pennsylvania	Disclosure: Dr. Bowling has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	033	Combined Treatment of Bilateral Periventricular Nodular Heterotopia with Laser Ablation and Neuropace Leads Placement after Stereo-EEG Evaluation	Disclosure: Dr. Podkorytova has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	033	Chronic Vestibular Syndrome Associated with Anterior Inferior Cerebellar Artery loop into the Internal Acoustic Meatus	Disclosure: Dr. Lawal has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	033	Levodopa doses and improvement in LRRK2 G2019S carriers compared to non-carriers	Disclosure: Dr. Farhat has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	033	Brain eating Balamuthia amoebic infection – A Case Report	Disclosure: Dr. Ballur Narayana Reddy has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	034	A cross sectional analytical study of cognitive impairment in survivors of spontaneous intracranial hemorrhage (ICH).	Disclosure: Dr. Gorthi has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	034	Integration and Characterization of Brain MRI Data from the Italian Neuroimaging Network Initiative (INNI) for the Study of Multiple Sclerosis	Disclosure: Dr. Storelli has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	034	Comparison of Clinical and Laboratory Features of Myasthenia Gravis in Different Ethnic, Gender and Age groups.	Disclosure: Dr. Pakneshan has nothing to disclose.
Epilepsy: Surgery and Imaging
Start Time	Pub.	Title	Presenter
11:30 AM	034	Stereoelectroencephalography following grids and strips: case series of six patients	Disclosure: Dr. Crowder has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	034	Cerebral Venous Sinus Thrombosis Associated with Electroconvulsive Therapy Resulting in Dural Arteriovenous Fistula	Disclosure: Dr. Al-Dulaimi has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	034	Trend in PEG placement in Parkinson's disease compared to Alzheimer dementia and ALS	Disclosure: Dr. Kim has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	034	Spinal Schistosomiasis masquerading as an Intramedullary Astrocytoma	Disclosure: Dr. Kvernland has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	035	Hypervitaminosis E and a-tocopherol levels in Intracranial Hemorrhagic Stroke	Disclosure: Dr. Le has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	035	Cognitive Impairment and Deep Grey Matter Lesions on 7T MRI in Multiple Sclerosis	Disclosure: Dr. Tomkinson has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	035	Successful Rituximab Desensitization In Two Patients With Myasthenia Gravis	Disclosure: Dr. Suh has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	035	Clinical and radiographic mismatch in fat embolism syndrome in hemoglobin SC disease	Disclosure: Dr. Moghbel has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	035	Endemic parkinsonism associated with the rare haplotype of LRRK2 gene	Disclosure: Dr. Mensikova has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	035	MRI findings and evolution of active or calcified cysts in treated and untreated patients with neurocysticercosis	Disclosure: Dr. Monteiro has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	036	Unusual intracerebral hemorrhagic (ICH) stroke presentation: Tumor to tumor metastasis.	Disclosure: Dr. Alvarado Arias has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	036	Cerebellar Volume Loss in Radiologically Isolated Syndrome	Disclosure: Dr. George has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	036	Volumetric Analysis and Densitiy of Extraocular Muscles in patients with Myasthenia Gravis	Disclosure: Dr. Kohler has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	036	Brainstem Posterior Reversible Encephalopathy Syndrome	Disclosure: Dr. Sanmartin has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	036	Case-based Medical Education Improves Neurologists’ Competence in Diagnosing and Managing Levodopa-induced Dyskinesia	Disclosure: Dr. Martorano has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	036	Neurotoxoplasmosis in Immunocompetent Patients Mimicking Lymphoproliferative Disease	Disclosure: Dr. Ferreira Lima has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	037	Simultaneous Ischemic stroke and Intracerebral Hemorrhage due to Amyloid Angiopathy presenting as a Therapeutic Challenge	Disclosure: Dr. Amin has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	037	Lower Total Cerebral Arterial Flow Contributes to Cognitive Performance in Multiple Sclerosis Patients	Disclosure: Dr. Jakimovski has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	037	Burden of Disease in Patients with Refractory Myasthenia Gravis	Disclosure: Dr. Sharma has nothing to disclose.
General Neurology: Neuroimaging and Disease
Start Time	Pub.	Title	Presenter
11:30 AM	037	Creutzfeldt-Jakob Disease Associated Longitudinally Extensive Transverse Myelitis; a Rare Presentation Accompanied By Rapid Disease Progression	Disclosure: Dr. Jordan has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	037	Risk Factors in Essential Tremors for the Development of Parkinson’s Disease vs Parkinsonism	Disclosure: Dr. Lau has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	037	New Diagnosed Active Neurocysticercosis: Serial Image Findings and Corresponding Clinical Manifestations	Disclosure: Dr. Rafiuddin has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	038	A Case of Cerebral Amyloid Angiopathy Associated Primary Progressive Aphasia	Disclosure: Dr. Pauta Martinez has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	038	Increased Iron Accumulation in Red Nucleus, Spelium, Putamen and Thalamus in Multiple Sclerosis and CIS: A 7 Tesla MRI Study	Disclosure: Dr. Kocer has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	038	Nocebo In Myasthenia Gravis: A Systematic Review And Meta-Analysis Of Randomized Placebo-Controlled Trials	Disclosure: Dr. Varma has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	038	Novel Mutation in ACSL4 Gene Leading to X-linked Intellectual Disability, Autism and ADHD	Disclosure: Dr. Gupta has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	038	Oral cavity disorders in Parkinson’s disease: more than meets the eye	Disclosure: Dr. Auffret has nothing to disclose.
Neurocysticercosis and Other Parasitic Infections
Start Time	Pub.	Title	Presenter
11:30 AM	038	An Unusual Radiographic Feature of Toxoplasma Encephalitis in Renal Transplant Recipient	Disclosure: Dr. Sugianto has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	039	Similarities and Differences in Intracerebral Hemorrhage Risk Factors by Race/Ethnicity	Disclosure: Dr. Kittner has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	039	Validation of the original FRESH score in patients with subarachnoid hemorrhage	Disclosure: Dr. Witsch has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	039	Loss of intrathalamic tissue integrity in pediatric-onset multiple sclerosis measured with DTI.	Disclosure: Dr. Datta has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	039	Retrospective longitudinal assessment of MG-ADL score with treatment of myasthenia gravis	Disclosure: Dr. Varon has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	039	Evaluation of Dystonia and Dystonic Posturing in a cohort of patients with autism spectrum disorder (ASD)	Disclosure: Dr. Ray has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	039	MANAGE-PD: A clinician-reported tool to identify patients with Parkinson's Disease inadequately controlled on oral medications – Results from vignette-based validation	Disclosure: Dr. Antonini has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acadia, Sunovion, UCB, Boston Scientific, Angelini, Medtronic, GE, Boehringer Ingelheim, AbbVie, Zambon. Dr. Antonini has received research support from Mundipharma.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	040	Mortality and Long Term Outcome after Spontaneous Intracerebral Hemorrhage	Disclosure: Dr. Mguidich has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	040	Role of Systemic Inflammatory Response Syndrome (SIRS) in Subarachnoid Hemorrhage (SAH) Outcome	Disclosure: Dr. Pandya has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	040	Impact of Cervical Stenosis on Multiple Sclerosis Lesion Distribution in the Spinal Cord	Disclosure: Dr. Gratch has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	040	Clinical and demographic features of LRP4 positive myasthenia gravis patients	Disclosure: Dr. Pesala has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	040	Genetic test results for 523 patients with ASD/ID: The diagnostic yield of multigene analysis (Autism/ID Xpanded test) is higher than conventional first-tier tests, such as FMR1 repeat analysis and chromosomal microarray	Disclosure: Dr. Shanmugham has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	040	Comorbidity and Polypharmacy in Parkinson's disease: comparative study with control group. Results from the COPPADIS Study Cohort.	Disclosure: Dr. Avila-Rivera has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	041	Primary Occipital Lobar Hemorrhages Associated with Lower 1 Year Mortality	Disclosure: Dr. Pan has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	041	Early uptrending white blood cell count can be a predictor of poor outcome in patients with aneurysmal subarachnoid hemorrhage	Disclosure: Dr. Azher has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	041	MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences	Disclosure: Dr. Azzolini has nothing to disclose.
Neuromuscular Junction Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	041	Elevated Antiganglioside Antibodies in a Case of Paraneoplastic Neuromuscular Junction Disorder	Disclosure: Dr. Jazebi has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	041	"Tell me with whom you walk, and I will tell you who you are”: A Social Network Analysis of Adolescents with ADHD	Disclosure: Dr. Arruda has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	041	Molecular and Genetic Characterization of Parkinson’s Disease: A Center-Wide Approach.	Disclosure: Dr. Tropea has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genzyme, Medtronics. Dr. Tropea has received research support from Sanofi.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	042	Role of Anti-Platelets & Anti-coagulants in Intracerebral hemorrhage: Analysis of a Large National Database	Disclosure: Dr. Suriya has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	042	Variability In Reported Physician Practices For Brain Death Determination	Disclosure: Dr. Braksick has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	042	Instrumental, Clinical, and Patient Reported Sensorimotor Correlates of Spinal Cord Grey and Total Cord Areas	Disclosure: Dr. Alexander has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	042	Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism status does not predict serum folate and B12 in children with Attention-Deficit/Hyperactivity Disorder (ADHD)	Disclosure: Dr. Silverstein has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	042	Novel Assistive Dress Shoe & Footwear Needs Analysis for Patients with Parkinson's Disease	Disclosure: Dr. Sayadi has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	043	Hemoglobin A1c in Intracerebral Hemorrhage: A Cross-sectional Analysis of a Large National Database.	Disclosure: Dr. Farooqui has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	043	Prediction of QTc interval prolongation using aneurysm location and bleeding pattern in aneurysmal subarachnoid hemorrhage.	Disclosure: Dr. Kinariwala has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	043	Functional Connectivity with the Default Mode Network Predicts Efficacy of Cognitive Rehabilitation in People with Multiple Sclerosis	Disclosure: Dr. Bartnik has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	043	Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and associated vitamin D levels in children with Attention-Deficit/Hyperactivity Disorder (ADHD)	Disclosure: Dr. Silverstein has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	043	Parkinsonian patients experiences operating the computer with their eyes: the MAMEM project.	Disclosure: Dr. Bostantjopoulou-Kambouroglou has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	044	A Unique Case of Cavum Veli Interpositum Hemorrhage in an Adult	Disclosure: Dr. Kaur has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	044	Radiological Severity Determines Glycemic Burden In Aneurysmal Subarachnoid Hemorrhage And Patient Outcome	Disclosure: Dr. Shujaat has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	044	Magnetization Transfer Saturation Reveals Subclinical Optic Nerve Demyelination in Pediatric Multiple Sclerosis	Disclosure: Dr. Longoni has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	044	A Prospective Open-label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder	Disclosure: Dr. Joshi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Governor's Council for Medical Research and Treatment of Autism, The Israeli Society for ADHD, Canadian Academy of Child and Adolescent Psychiatry, University of Juelich. Dr. Joshi has received personal compensation in an editorial capacity for NIMH. Dr. Joshi has received research support from Pfizer Inc., F. Hoffmann-La Roche Ltd., NIH-NIMH, Simons Center for the Social Brain.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	044	Jumping as a Strategy to Overcome Freezing of Gait while Turning in Parkinson’s Disease	Disclosure: Dr. Lizarraga has nothing to disclose.
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Start Time	Pub.	Title	Presenter
11:30 AM	045	Validation of ICH and ICH-GS scores in cohort of Indian patients with Intracerebral hemorrhage	Disclosure: Dr. Malapur has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	045	Predictors of 30-day readmissions and in-hospital mortality amongst patients admitted with aneurysmal subarachnoid hemorrhage-Insights from National Database	Disclosure: Dr. Kara has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	045	Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: a case-controlled magnetization transfer ratio study	Disclosure: Dr. Dwyer has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Serono Novartis and Claret Medical. Dr. Dwyer has received research support from Novartis and Celgene.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	045	Disparities in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents - a Nationwide Study	Disclosure: Dr. Arruda has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	045	Non-invasive Assessment of Dysphagia in Degenerative Disorder (Parkinson’s Disease)	Disclosure: Dr. Gudwani has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	046	Decreased Odds for Vasospasm Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage After Transitioning from Neurosurgery-Led Care to a Neurology-Led Multidisciplinary Approach	Disclosure: Dr. Bartt has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	046	Correlation between Magnetization Transfer Ratio and Functional Status in Multiple Sclerosis patients	Disclosure: Dr. Ebrahim has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	046	Early Ischemic Changes on Serial CT Imaging in Acute Ischemic Stroke	Disclosure: Dr. Czap has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	046	Novel Research Initiatives for Early Recognition and Comprehensive Management of Autism Spectrum Disorder to Empower Health Professionals and Health Care Providers: Two Decade Experience from a Tertiary Care Centre in India	Disclosure: Dr. Panda has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	046	Vitamin D Assessment in Veterans with Parkinson’s Disease	Disclosure: Dr. Jamal has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	047	Role of Glycemic Burden and Glycemic Burden Variability in Determination of Temporary and Permanent Cerebrospinal Fluid diversion after Aneurysmal Subarachnoid Hemorrhage	Disclosure: Dr. Muzammil has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	047	Dynamics of Pseudo-Atrophy in RRMS Patients Treated with Interferon beta-1a as Assessed by Monthly Brain MRI	Disclosure: Dr. De Stefano has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Serono S.A., Teva Pharmaceutical Industries, Novartis Pharma AG, BayerSchering AG, SanofiAventis and Serono Symposia International Foundation.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	047	The Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome	Disclosure: Dr. Kimmel has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	047	Health Care Transition and Longitudinal Care for Adolescents and Young Adults with Hydrocephalus	Disclosure: Dr. Williams has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	047	Impact of Parkinson’s Disease on Faith and Spirituality - a Comparative Study	Disclosure: Dr. Worku has nothing to disclose.
Neurocritical Care: Subarachnoid Hemorrhage
Start Time	Pub.	Title	Presenter
11:30 AM	048	Lactococcus garvieae endocarditis with an initial presentation of subarachnoid hemorrhage	Disclosure: Dr. Purushothaman Ravichandran has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	048	Resting-state functional correlates of Social Cognition in Multiple Sclerosis	Disclosure: Dr. Bisecco has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Genzyme, Merck.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	048	To CTA or Not to CTA: Should We Continue to Order CT Angiography of Head and Neck in Patients with TIA?	Disclosure: Dr. Bach has nothing to disclose.
Child Neurology: Autism and Behavioral Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	048	Assessing Effectiveness of an Educational Intervention on Gaps in Child Neurology Knowledge for Pediatric Residents	Disclosure: Dr. Rahman has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	048	Prevalence and clinical correlates of metabolic syndrome in patients with Parkinson’s disease.	Disclosure: Dr. Meléndez-Flores has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	049	Cortical Thickness, Subcortical Volumes and Disability in Multiple Sclerosis: A Prospective Longitudinal Study	Disclosure: Dr. Kakara has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	049	Tissue Based Selection for Large Vessel Occlusion Thrombectomy Leads to Similar Functional Outcomes in Conventional (0-6 hours) and Extended (>6 hours) Window	Disclosure: Dr. Bhan has nothing to disclose.
Child Neurology: Epilepsy II
Start Time	Pub.	Title	Presenter
11:30 AM	049	In Silico Predictions of KCNQ Channel Variant Pathogenicity in Epilepsy	Disclosure: Dr. Ritter has nothing to disclose.
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	049	Sporadic Parkinson's Disease and Amyotrophic Lateral Sclerosis: A New Syndrome?	Disclosure: Dr. Puri has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	049	Epidemiological Factors Influencing Organ Donation Following Brain Death	Disclosure: Dr. Green has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	050	Nystagmus-associated imaging signatures in Multiple Sclerosis: evaluation of subcortical and infratentorial structures	Disclosure: Dr. Bede has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	050	Underestimation of Ischemic Core on Perfusion CT in Patients with Acute Large Vessel Occlusion: Results from the BEST Prospective Cohort Study	Disclosure: Dr. Siegler has nothing to disclose.
Child Neurology: Epilepsy II
Start Time	Pub.	Title	Presenter
11:30 AM	050	Correlations between genetic, biochemical, and clinical characteristics in glucose transporter 1 deficiency syndrome: a single-center study.	Disclosure: Dr. Nabatame has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB Japan Co Ltd., Eisai Co. Ltd., Otsuka pharmaceutical Co., Shindan to Chiryo Sha. Dr. Nabatame has received research support from Eisai Co., Otsuka pharmaceutical Co., UCB Japan, Meiji Seika Pharma Co., Alfresa Co., Takeda Pharmaceutical Co., Biogen Japan, Japan Blood Products Organization, Kyowa Hakko Kirin Co..
Parkinson's Disease Clinical Features and Clinical Care II
Start Time	Pub.	Title	Presenter
11:30 AM	050	Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach	Disclosure: Dr. Chahine has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	050	Two Cases of Fulminant Acute Motor and Sensory Axonal Neuropathy Mimicking Brain Death	Disclosure: Dr. Rodrigo has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	051	Spine atrophy and sensory-motor disability in African Americans with Multiple Sclerosis	Disclosure: Dr. El Mendili has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	051	Computed Tomography Perfusion Imaging in Evaluation of Patients With Acute Stroke is Not Associated With Increased Risk of Acute Kidney Injury	Disclosure: Dr. Satkowiak has nothing to disclose.
Child Neurology: Epilepsy II
Start Time	Pub.	Title	Presenter
11:30 AM	051	Clinical Decision Support to Promote SUDEP Discussions	Disclosure: Dr. Downs holds stock and/or stock options in Digital Health Solutions, LLC. Dr. Downs has received research support from Digital Health Solutions, LLC.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	051	Bobbing-Like Ocular Movements in a Patient with Brain Death	Disclosure: Dr. McDaniel has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	052	Influence of T2-Hyperintense Lesions on Cervical Spinal Cord Atrophy and Disability in Patients with Multiple Sclerosis	Disclosure: Dr. Rocca has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Novartis, Genzyme, Sanofi-Aventis, Teva, Merck Serono, and Roche.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	052	Computed Tomography Perfusion provides clinically relevant core infarct for thrombectomy selection	Disclosure: Dr. Shaker has nothing to disclose.
Child Neurology: Epilepsy II
Start Time	Pub.	Title	Presenter
11:30 AM	052	Evolution of Dietary Therapies in Treatment of Childhood Drug Resistant Epilepsy: an overview of nine studies including six randomized controlled trials accomplished over last twelve years in a tertiary care teaching hospital in North India	Disclosure: Dr. Gulati has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	052	End of Life Preferences: Medical Students’ Attitudes Toward Life Support	Disclosure: Dr. Zhong has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	053	Changes in Brain Volume in Specific Regions could be related to Disability Progression in Primary Progressive Multiple Sclerosis Patients	Disclosure: Dr. Perez Miralles has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	053	Clinical and imaging features of contrast induced neurotoxicity after cerebral angiography – Case series	Disclosure: Dr. Zevallos has nothing to disclose.
Child Neurology: Epilepsy II
Start Time	Pub.	Title	Presenter
11:30 AM	053	Safety Education by Frontline Providers in Pediatric Patients with Suspected Seizures	Disclosure: Dr. Freedman has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	053	Outcomes in Neurologically Critically Ill Patients with Fixed Dilated Pupils: A Retrospective Cohort Study	Disclosure: Dr. Kornspun has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	054	Is there a relationship between Incidental Learning and Self-temporal Projection in relapsing remitting multiple sclerosis patients?	Disclosure: Dr. Rodrigo has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	054	Ischemic Stroke Subtyping, Based on Vascular Imaging: A University Hospital Based Study	Disclosure: Dr. Shahidullah has nothing to disclose.
Child Neurology: Epilepsy II
Start Time	Pub.	Title	Presenter
11:30 AM	054	Late-onset Rasmussen encephalitis: Diagnosis Difficulty	Disclosure: Dr. Sansa has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	054	The Successful Implementation of a TBI Brain Donation Pathway	Disclosure: Dr. Silverman has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	055	Resting State Network Functional Connectivity Abnormalities in Systemic Lupus Erythematosus: Correlations with Neuropsychological and Neuropsychiatric Variables	Disclosure: Dr. Bonacchi has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	055	Focal Parietal Lobe Atrophy in Antiphospholipid Syndrome: Retrospective Analysis	Disclosure: Dr. Wong has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	055	Mesenchymal Stem/Stromal Cell Therapy during Pediatric Cardiac Surgery on Neurogenesis in the Porcine Subventricular Zone	Disclosure: Dr. Kapani has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	055	Characterization of acute traumatic cerebral venous sinus thrombosis	Disclosure: Dr. Schwartz has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	056	Gray Matter Volume Loss Is Increased in Younger Patients With Relapsing Multiple Sclerosis but Minimized by Ozanimod: Experience From the Ozanimod Phase 3 Program	Disclosure: Dr. Schippling has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Merck, Sanofi.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	056	Hazy DWI Restriction in Pons on Hyperacute MRI: DWI 'Smog Sign’	Disclosure: Dr. Ikram has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	056	Novel In Vivo Model of Prenatal Hypoxic Injury and Genetic Mitochondrial Hyposufficiency	Disclosure: Dr. Cristancho has nothing to disclose.
Neurocritical Care: Brain Death and Traumatic Brain Injury
Start Time	Pub.	Title	Presenter
11:30 AM	056	Implementation of Attending-Supervised IPASS Handoffs in the Neuro-ICU	Disclosure: Dr. Cifrese has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	057	Utility of Digital Ophthalmoscope in Neurology Residency	Disclosure: Dr. Chima has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	057	Deep learning enables thalamic atrophy measurement on clinical quality T2 FLAIR images	Disclosure: Dr. Dwyer has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Serono Novartis and Claret Medical. Dr. Dwyer has received research support from Novartis and Celgene.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	057	Cardiovascular and metabolic risk factors for the development of cerebral small vessel disease: Longitudinal FLAIR imaging in the Mayo Clinic Study of Aging	Disclosure: Dr. Scharf has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	057	Estrogen receptor GPR30 is participated in the long-term adverse effect of neonatal dexamethasone treatment in female rats	Disclosure: Dr. Lo has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	058	Does Non-automated Phone Call Notification Improve No-Show Rates in Neurology Resident Clinic?	Disclosure: Dr. Alshammaa has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	058	Brain Volume Loss and Cognition in Teriflunomide-Treated Patients in TEMSO	Disclosure: Dr. Wuerfel has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Biogen Novartis Roche.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	058	Imaging of angiogenesis in white matter hyperintensities using simultaneous 68Ga-NOTA-PRGD2 PET/MRI	Disclosure: Dr. Ding has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	058	Sleep Disturbances in Pediatric Intracranial Hypertension	Disclosure: Dr. Kornbluh has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	059	Gender disparities in course speakers at the AAN Annual Meeting	Disclosure: Dr. Figurelle has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	059	Effect of Treatment Naiveté on MRI Outcomes with Fingolimod or Injectable Disease-Modifying Therapies in Patients with Multiple Sclerosis: PREFERMS	Disclosure: Dr. Hunter has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie, Acorda Therapeutics, Actelion, Adamas, Avanir, Bayer HealthCare, Novartis, Osmotica, Roche/Genentech, Sanofi-Genzyme and Teva Neuroscience. Dr. Hunter has received research support from Actelion, Adamas, Avanir, Bayer HealthCare, Novartis, Roche/Genentech, Sanofi-Genzyme and Teva .
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	059	Case Report: Sonographic demonstration of a perfusion dependent stroke with negative MRI and a flow limiting stenosis	Disclosure: Dr. Gomez has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	059	Neurocognitive outcomes and their Diffusion Tensor Imaging (DTI) correlates in children with Mild Traumatic Brain Injury (mTBI)	Disclosure: Dr. Madaan has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	060	Perception of Futile Provision of Care among Clinicians in the Neurointensive Care Unit	Disclosure: Dr. Chalela has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	060	Magnetic Resonance Imaging Measures as Prognostic Parameters for Physical and Cognitive Outcomes up to 8 Years in Patients with Relapsing Forms of Multiple Sclerosis	Disclosure: Dr. Vollmer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Academic CME, Alcimed, Anthem Blue Cross, Genentech/Roche, Biogen IDEC, Novartis, CellGene, Epigene, Rocky Mountain MS Center, GLG Consulting, Ohio Health, TG Therapeutics, Topaz Therapeutics, Dleara Lawyers, Teva. Dr. Vollmer has received research support from Teva, NIH/NINDS, Rocky Mountain MS Center, Actelion, Roche/Genentech, UT Southwestern, TG Therapeutics.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	060	Transcranial Doppler-detected Microembolic Signals as a Predictor of New Brain Ischemic Lesion after Elective Coronary Intervention	Disclosure: Dr. Herzig has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer. Dr. Herzig has received personal compensation in an editorial capacity for Ambit Media.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	060	Neurologic Sequelae of Infective Endocarditis in Children	Disclosure: Dr. Favilla has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	061	Impact of doing Echocardiogram and Brain Magnetic Resonance Imaging on Length of Stay and Hospital Charges in Transient Ischemic Attack Patients in United States: Analysis of Nationwide Inpatient Sample 2006-2014	Disclosure: Dr. Bandaru has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	061	Regional Myelin-Specific MRI Abnormalities in Susac Syndrome Suggests Demyelination is a Pathologic Feature	Disclosure: Dr. Johnson has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	061	Subclinical peripheral arterial disease in patients with acute ischemic stroke; study with an ultrasonography	Disclosure: Dr. HA has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	061	Favorable Outcome in Children and Adults with PRES despite Clinical and Radiological Differences	Disclosure: Dr. Young has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	062	Regional Variation in Medicare Part D Drug Spending Amongst Neurologists	Disclosure: Dr. De Havenon has received research support from AMAG Pharmaceuticals and Regeneron Pharmaceuticals.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	062	Long-Term Monitoring Of Brain Volume Loss In Multiple Sclerosis	Disclosure: Dr. Pawlak has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Novartis, Roche.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	062	The Perplexing Texting of Dystextia – Whynn th Mesrage Indcates Thar Is A Probm	Disclosure: Dr. Anderson has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	062	Fetal Pain: A Review of Available Evidence	Disclosure: Dr. Berns has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	063	AAN Axon Registry: Limitation and Barriers to Optimal Participation and Performance at an Academic center	Disclosure: Dr. Garg has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	063	Atrophied T2 lesion volume and cognitive outcomes in multiple sclerosis	Disclosure: Dr. Tavazzi has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	063	Acute anterior thalamic infarcts affecting Memory and Cognition- an important but less well known lacunar syndrome	Disclosure: Dr. Nandanwar has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	063	Psychogenic Gait Disorder Complicating Recovery after Concussion: A Case Series	Disclosure: Dr. Otallah has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	064	A Survey of Attitudes Towards Genetic Testing in Amyotrophic Lateral Sclerosis (ALS)	Disclosure: Dr. Xiao has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	064	Global and regional brain atrophy in highly active MS-A biomarker for therapy switch	Disclosure: Dr. Raji has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Serono, Genzyme, Novartis. Dr. Raji has received research support from Genzyme.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	064	Lesion Topography and Its Correlation with Etiology in Medullary Infarction: Analysis from a Multi-Center Stroke Study in China	Disclosure: Dr. Hong has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	064	Kernicterus in the 21st Century: Bilirubin-Induced Brain Injury Due to Glucose-6-Phosphate Dehydrogenase Deficiency	Disclosure: Dr. Chen has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	065	Use of a Philadelphia Specific Spanish Toolkit in the neurology outpatient clinic in Temple University Hospital	Disclosure: Dr. Jacobson has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	065	Myelinating Proteins in MS are Linked to Volumetric Brain MRI changes	Disclosure: Dr. Brod has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	065	Bilateral Medial Medullary Syndrome with Atypical Clinical Presentation and Brain MRI Findings	Disclosure: Dr. Farooqui has nothing to disclose.
Injury in Developing Brain: Fetal Neurology, Trauma and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	065	Caffeine Augments Anesthesia Neurotoxicity in the Fetal Macaque Brain	Disclosure: Dr. Noguchi has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	066	Trigeminal nerve root enhancement in multiple sclerosis	Disclosure: Dr. Rukmangadachar has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	066	Floating Heads: An Occi-dental Discovery of Bálint Syndrome	Disclosure: Dr. Rathnam has nothing to disclose.
Child Neurology: Neuromuscular Disease: Birth to Adulthood II
Start Time	Pub.	Title	Presenter
11:30 AM	066	Strengthening knowledge when data are scarce: the role of social media after AFM.	Disclosure: Dr. Bove has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion, Roche Genentech, Novartis, EMD Serono, Biogen, Sanofi Genzyme, and Pear Digital.. Dr. Bove has received research support from Akili Interactive..
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	067	Transition of Care from Child to Adult Neurologists: Implementation and Financial Strategies for Child and Adult Neurologists	Disclosure: Dr. Cohen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stealth Biotheraputics, Modis (aka Meves) Pharmaceuticals, NeuroVive, MitoBridge, AAN for CPT Consulting and Educational Activities. Dr. Cohen has received research support from Dr. Cohen has received research support from Stealth Biotherapeutics, BioElectron Technologies.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	067	Short-term MRI-based Prediction of Clinical MS Progression in a Real World Setting	Disclosure: Dr. Van Hecke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with icometrix.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	067	Novel Neuroimaging Pattern In A Patient With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy	Disclosure: Dr. Petrea has nothing to disclose.
Child Neurology: Neuromuscular Disease: Birth to Adulthood II
Start Time	Pub.	Title	Presenter
11:30 AM	067	A Case of Rapidly Progressive Juvenile-Onset Amyotrophic Lateral Sclerosis with a rare SOD1 genetic variant	Disclosure: Dr. De La Torre Ribadeneira has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	068	Challenges with the use of Prehospital Stroke Scales for early identification of Large Vessel Occlusion Strokes.	Disclosure: Dr. Rahangdale has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	068	The Effect of Glitiramer Acetate 40mg TIW on Multiple Brain MRI Parameters over One Year	Disclosure: Dr. Rube has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	068	Transient Smartphone Blindness: An Unusual Cause of Vision Loss in the 21st Century	Disclosure: Dr. Rondeau has nothing to disclose.
Child Neurology: Neuromuscular Disease: Birth to Adulthood II
Start Time	Pub.	Title	Presenter
11:30 AM	068	Stiff Person Syndrome: An Elusive Diagnosis in a Pediatric Patient	Disclosure: Dr. Tuttrup has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	069	Establishing a resident-led lumbar puncture clinic to improve resident satisfaction and skills during neurology residency	Disclosure: Dr. Sader has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	069	Thalamic nuclei volumes as markers of clinical disability and cognitive dysfunction in multiple sclerosis	Disclosure: Dr. Bergsland has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Imaging and Localization
Start Time	Pub.	Title	Presenter
11:30 AM	069	Non-invasive Longitudinal Assessment of Cerebrovascular Reactivity after TBI using functional Near Infrared Spectroscopy	Disclosure: Dr. Sangobowale has nothing to disclose.
Child Neurology: Neuromuscular Disease: Birth to Adulthood II
Start Time	Pub.	Title	Presenter
11:30 AM	069	Early onset congenital myopathies and LGMD phenotype investigated by muscle MRI in two trasportinopathy families	Disclosure: Dr. Marozzo has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	070	Contribution towards Public Health Awareness Activities and Continuing Medical education for Empowering Health Care Professionals on Childhood Neurodevelopmental Disorders: Experience of a Tertiary Care Teaching Hospital in North India over the last decade-Going E-way	Disclosure: Dr. Panda has nothing to disclose.
MS Neuroimaging
Start Time	Pub.	Title	Presenter
11:30 AM	070	Volume Loss in Deep Gray Matter and Thalamic Sub-Nuclei in Placebo-treated Patients with Multiple Sclerosis in the Phase 3 TEMSO Study	Disclosure: Dr. Magon has nothing to disclose.
Child Neurology: Neuromuscular Disease: Birth to Adulthood II
Start Time	Pub.	Title	Presenter
11:30 AM	070	Juvenile Myasthenia Gravis: Evaluation of presentation and treatment outcomes in a large cohort	Disclosure: Dr. Gill has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	071	Perceptions of Preventive Stroke Care Received by Women in Different Primary Care Settings	Disclosure: Dr. Atlas has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	071	Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.	Disclosure: Dr. Graf has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	072	Strategies to Decrease Post Hospital Discharge Negative Outcomes for Patients with Neurological Diseases.	Disclosure: Dr. Smith has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	072	Naturally Occurring Anti-Neuronal Antibodies within IVIg Preparations: Importance in Clinical Practice	Disclosure: Dr. Dimitriadou has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	073	Quality Improvement in Laboratory Analysis of Paraneoplastic Panels	Disclosure: Dr. Bajaj has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	073	Isoagglutinin Reduction In IVIG By Specific Immunoaffinity Chromatography Reduces Spontaneous Reporting Rates Of Hemolytic Reactions	Disclosure: Dr. Shebl has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with CSL Behring GmbH.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	074	Improving Patient Return to Residency Clinic using a Patient Portal: A Residency Quality Improvement Project	Disclosure: Dr. Kyrtsos has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	074	Adrenal Insufficiency and Multiorgan Failure in a Patient Receiving Alemtuzumab Therapy	Disclosure: Dr. Miller has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	075	Evaluation of the Duke Neurology Advanced Practice Provider Training Program	Disclosure: Dr. Morgenlander has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	075	Long-term efficacy of intravenous immunoglobulin treatment in 49 patients with chronic inflammatory demyelinating polyradiculoneuropathy	Disclosure: Dr. Seybold has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	076	Effects of a novel practice model on medical team burnout in an academic neurology practice	Disclosure: Dr. Kern has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AbbVie Pharmaceuticals, Merz Pharma and SAI-Med Partners, LLC.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	076	Analysis of Relapse by MRC Sum Score in the PATH Study of Subcutaneous Immunoglobulin in CIDP	Disclosure: Dr. Bril has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with CSL Behring UCB Alnylam Argenx Alexion Grifols Octapharma Shire (Takeda) Pfizer and PowellMansfield. Dr. Bril has received research support from CSL Behring UCB Grifols Argenx Biogen and Octapharma.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	077	Improving neurologists’ adherence to guidelines on prevention of possible complications of systemic corticosteroid therapy	Disclosure: Dr. Samara has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	077	The effect of oral Steriods in Chronic Demyelinating Polyneuropathy associated with Diabetes Mellitus	Disclosure: Dr. Singh has nothing to disclose.
Practice, Policy, and Ethics II
Start Time	Pub.	Title	Presenter
11:30 AM	078	First Year Experience at SAC Health System, the First Federally Qualified Health Center (FQHC) Based Neurology Clinics	Disclosure: Dr. Baker has nothing to disclose.
Immunotherapies: New Targets and Side Effects
Start Time	Pub.	Title	Presenter
11:30 AM	078	Treatment Satisfaction and Work Productivity in a Clinical Study of IgPro20 Maintenance Treatment of CIDP	Disclosure: Dr. Hartung has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer Healthcare, Biogen, Geneuro, Genzyme, Medimmune, Merck, Receptos Celgene, Novartis, Roche, CSL Behring.
11:30 AM	079	RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration	Disclosure: Dr. Collins has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roivant Sciences, Inc; Immunovant, Inc.
11:30 AM	080	Changes in Concomitant Immunosuppressive Therapy Use During a Phase 3 Open-label Study of Eculizumab in Adults with Generalized Myasthenia Gravis: an Interim Analysis	Disclosure: Dr. Nowak has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion, Ra Pharma, Momenta, Grifols, Roivant. Dr. Nowak has received research support from Alexion, Ra Pharma, Genentech, Grifols.
11:30 AM	081	Molecular Characterization of VEGF Secretion by MSC-NTF Cells (NurOwn®): Therapeutic Implications in ALS	Disclosure: Dr. Kaspi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with BrainStorm Cell Therapeutics.
11:30 AM	082	Saturation of alpha4 integrin (CD49d) in patients undergoing treatment with natalizumab in extended interval dose.	Disclosure: Dr. Zhu has received research support from Biogen (past year), Merck.
11:30 AM	083	Precision Therapy for Neuromyelitis Optica Spectrum Disorder: A Retrospective Analysis of the Use of Class-Switched Memory B-cells for Individualized Rituximab Dosing Schedules	Disclosure: Dr. Trewin has nothing to disclose.
11:30 AM	084	New Sensorineural Hearing Loss can be Associated with Disabling Autoimmune Disease	Disclosure: Dr. Ghavami has nothing to disclose.
MS Symptom Assessment and Management
Start Time	Pub.	Title	Presenter
11:30 AM	085	Long-term Effectiveness of 9-d-tetrahydrocannabinol:Cannabidiol Oromucosal Spray in Clinical Practice: results from a 18-months Multicenter Italian Study	Disclosure: Dr. Patti has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Almirall, Bayer, Biogen, Celgene, Merck, Myalin, Novartis, Roche, Sanofi-Genzyme and Teva. Dr. Patti has received research support from MIUR (Ministero Italiano della Università della Ricerca Scientifica), FISM (Fondazione Italiana Sclerosi Multipla), Biogen and Merck.
11:30 AM	086	Feasibility of Using Wearable Technology with a Social Cognitive Theory-based Physical Activity Promotion Program in Youth with Multiple Sclerosis	Disclosure: Dr. Grover has nothing to disclose.
11:30 AM	087	INROADS: A Phase 3 Study to Assess the Efficacy and Safety of ADS-5102 (Amantadine) Extended Release Capsules in Multiple Sclerosis (MS) Patients with Walking Impairment	Disclosure: Dr. Cameron has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Adamas Corporation and GW Pharmaceuticals. Dr. Cameron has received personal compensation in an editorial capacity for Current Neurology and Neuroscience Reports.
11:30 AM	088	Which treatments improve fatigue and quality of life in Multiple Sclerosis? Evidence appraisal and development of visual interactive evidence maps	Disclosure: Dr. Tsou has nothing to disclose.
11:30 AM	089	Sexual Dysfunction in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Prevalence	Disclosure: Dr. Kim has nothing to disclose.
11:30 AM	090	Interoception as a neurocognitive mechanism underlying fatigue in Multiple Sclerosis	Disclosure: Dr. Gonzalez Campo has nothing to disclose.
11:30 AM	091	Origins of Fatigue in an Early Multiple Sclerosis Cohort	Disclosure: Dr. Marino has nothing to disclose.
11:30 AM	092	A Survey of Cannabis-Based Product Use in Multiple Sclerosis Patients at the University of British Columbia Hospital	Disclosure: Dr. Schabas has nothing to disclose.
11:30 AM	093	N-acetyl cysteine for fatigue in progressive multiple sclerosis: A pilot randomized double-blind placebo-controlled trial	Disclosure: Dr. Krysko has received research support from MS fellowship grant from NMSS; MS fellowship grant from Biogen.
11:30 AM	094	Telerehabilitation reduces travel cost and time: A survey of participants with multiple sclerosis in an urban treatment setting	Disclosure: Dr. Best has nothing to disclose.
11:30 AM	096	The Extent of the Relationship between Sleep Disturbances and walking ability in People with Multiple Sclerosis	Disclosure: Dr. El-Salem has nothing to disclose.
11:30 AM	097	A Novel Approach to Treatment of Trigeminal Neuralgia in Multiple Sclerosis Patients Using Minimally Invasive Trigeminal Ablation (MITA)	Disclosure: Dr. Tajali has nothing to disclose.
11:30 AM	098	Lacosamide Efficacy in Trigeminal Neuralgia and Other Neuropathic Pain Syndromes: A Case Series	Disclosure: Dr. Belliston has nothing to disclose.
11:30 AM	099	Social anxiety among patients with multiple sclerosis: a population-based case-control study in Ecuador	Disclosure: Dr. Jimenez-Zambrano has nothing to disclose.
11:30 AM	100	Cannabis Use in People with Multiple Sclerosis and Self-Reported Spasticity	Disclosure: Dr. Hugos has nothing to disclose.
11:30 AM	101	Gait and Balance Outcomes in Adrenomyeloneuropathy (AMN)	Disclosure: Dr. Sadjadi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with HVHPrecision.
11:30 AM	102	Processing speed of information deficit induces a lack of functional impulsivity in Multiple Sclerosis	Disclosure: Dr. Joly has nothing to disclose.
11:30 AM	103	Arabic Modified Fatigue Impact Scale: Validity and Reliability in People with Multiple Sclerosis	Disclosure: Dr. Alsharman has nothing to disclose.
11:30 AM	104	Cognitive-motor interaction in Multiple Sclerosis: how it impacts on patient’s Quality of Life.	Disclosure: Dr. Eizaguirre has nothing to disclose.
11:30 AM	105	Immunophenotyping of Depression and Fatigue in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Dimethyl Fumarate	Disclosure: Dr. Lee has nothing to disclose.
11:30 AM	106	Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review Evaluating Symptom Outcomes	Disclosure: Dr. McCormack has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Mallinkrodt, Biogen and Sanofi Genzyme.
11:30 AM	107	Evidence of early Central Nervous System degeneration in Multiple Sclerosis patients with impulsivity	Disclosure: Dr. Capet has nothing to disclose.
11:30 AM	108	Prevalence and Factors Associated with Anxiety in Argentinian Patients with Multiple Sclerosis	Disclosure: Dr. Chertcoff has nothing to disclose.
11:30 AM	109	Demyelinating Disease Associated with Parkinsonism: A Case Report	Disclosure: Dr. Jordan has nothing to disclose.
11:30 AM	110	Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases	Disclosure: Dr. Kizek has nothing to disclose.
11:30 AM	111	The "MS Hug": Definition, Characteristics, Course, and Misattribution Risk	Disclosure: Dr. Wingerchuk has received personal compensation from MedImmune, Celgene, Novartis Dr. Wingerchuk has received personal compensation in an editorial capacity as co-Editor-in-Chief for The Neurologist. Dr. Wingerchuk has received research support from Alexion and TerumoBCT.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
7:00 AM-9:00 AM
C1 - What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C3 - Clinical EEG: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading Selim Benbadis MD, FAAN
C4 - Pediatric Neuro-ophthalmology Update Christopher Glisson DO, FAAN
C6 - Therapy of Movement Disorders: A Case-based Approach David Riley MD
C7 - Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
C8 - Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Louis Caplan MD, FAAN
8:00 AM-8:30 AM
Are you My Mentor? How to Select a Good Mentor for Your Research Center Deborah Hall MD, PhD, FAAN
9:00 AM-9:30 AM
What Should Applicants Look for in a Program? Adam De Havenon MD
How to Successfully Publish Quality Improvement Projects Anup Patel MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
9:30 AM-11:30 AM
C12 - Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing Tahseen Mozaffar MD, FAAN
C13 - Clinicopathological Correlation Session in Dementia David Irwin MD
C14 - Child Neurology: Headache Amy Gelfand MD
C15 - Clinical EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults Katherine Noe MD, PhD, FAAN
C16 - Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
C18 - Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
C19 - Multiple Sclerosis Overview I: Clinical Pearls Mary Willis MD
C20 - Neurologic Complications of Medical Disease Sara Hocker MD, FAAN
10:00 AM-10:30 AM
Quality Improvement Research in Neurology Mona Bahouth MD
11:00 AM-11:30 AM
Your CV Is Talking About You Behind Your Back and Your LORs Are, Too! Na Tosha Gatson MD, PhD
11:00 AM-11:45 AM
How to Become a Leader in Your Health System Lyell Jones MD, FAAN, Eric Cheng MD, MS, FAAN
Fellowship as a Springboard to Junior Faculty Kathryn Nevel MD
12:00 PM-12:30 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
12:00 PM-4:00 PM
C24 - Leadership Challenges in Practice Brad Klein MD, MBA, FAAN
1:00 PM-1:30 PM
Statistics: Sample Size William Meurer MD
1:00 PM-1:45 PM
Tips and Tools for Successful Recruitment Peggy Nolty
What's Going On With E/M? Luana Ciccarelli , Bruce Cohen MD, FAAN
1:30 PM-3:30 PM
C25 - Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Tahseen Mozaffar MD, FAAN
C26 - Clinical EEG: Neonatal and Pediatric Nicholas Abend MD
C27 - Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Andrew Naidech MD, FAAN
C34 - Evaluating Tremor in the Office Andres Deik Acosta Madiedo MD
C29 - Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
C30 - Neurologic Complications of Medical and Surgical Therapies Sara Hocker MD, FAAN
C31 - Mitochondrial Disorders in Neurology Michio Hirano MD, FAAN
C32 - The Neurology of Social Behavior Bradford Dickerson MD, FAAN
C33 - Teleneurología (Teleneurology) Susana Bowling MD
1:45 PM-2:30 PM
The Experience of Music Therapy in the Interdisciplinary Treatment of TBI Renee Pazdan MD, FAAN, Rebecca Vaudreuil EdM, MT-BC
2:00 PM-2:45 PM
A Career in Neuroimaging Michael Hutchinson MD, PhD
2:30 PM-3:15 PM
Dancing with Parkinson's Diviya Kaul MD
2:45 PM-3:30 PM
Case Studies: Ethical Conundrums in Neurology Winston Chiong MD, Ariane Lewis MD, Justin Sattin MD, Daniel Larriviere MD, JD, FAAN, James Russell MD, MS, FRPC, FAAN, William Graf MD, FAAN, Salvador Cruz-Flores MD, FAAN
3:00 PM-3:45 PM
Using Technology to Get Real Answers from Your Patients Lidia Maria Moura MD, FAAN
Interventional Neurology: Training and Practice Adnan Qureshi MD
3:00 PM-4:00 PM
AAN Business Meeting
3:45 PM-4:45 PM
Women in Neurology Jennifer Bickel MD, FAAN, Veronica Santini MD, MA, Meeryo Choe MD, Renee Pazdan MD, FAAN
4:00 PM-4:45 PM
Opioids: What Is Your State Doing to Confront This Epidemic? Donn Dexter MD, FAAN
4:15 PM-5:30 PM
Hot Topics Plenary Session Eric Klawiter MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
Telestroke Across the Continuum Amy Guzik MD
5:45 PM-6:45 PM
Advancing Medicine: Inspiration and Innovation Featuring Hugh Herr, PhD Hugh Herr PhD

Sunday, May 5, 2019
7:00 AM-7:30 AM
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Resident Evaluation of Faculty: A New Approach Deborah Fay
7:00 AM-9:00 AM
C46 - Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder) Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN
C36 - Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
C37 - Chronic Traumatic Encephalopathy: Update Andrew Budson MD
C40 - Child Neurology: Stroke Lori Billinghurst MD
C42 - The Dystonias: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
C43 - Residents in Private Practice Anil Dhuna MD, FAAN
C44 - Multiple Sclerosis Therapy: Symptom Management Andrew Solomon MD, FAAN
C45 - Status Epilepticus Stephan Schuele MD, FAAN
8:00 AM-8:30 AM
C260 - Accreditation Step by Step: From Self Study to Site Visit Crys Draconi
Neuroscience of Bias Jose Posas MD
Clerkship Director Conversation Rachel Marie Salas MD, FAAN
8:00 AM-8:45 AM
Coding for Residents Kavit Shah MD
8:30 AM-9:00 AM
C261 - How to Become An Advocate For Yourself and Your Program Sana Ghafoor MD
Neuroscience Course Director Conversation Peter Hannon MD, Madhu Soni MD, FAAN
9:00 AM-10:00 AM
C262 - Choosing, Training, Forging, and Mentoring Chief Residents: Program Coordinator Role Marla Scofield C-TAGME
9:15 AM-12:00 PM
Presidential Plenary Session Natalia Rost MD, MPH, FAAN, FAHA
11:30 AM-6:30 PM
P1 - Poster Session 1
12:00 PM-12:45 PM
Almuerzo con Colegas: Perlas clínicas/ solicitando una residencia o subespecialidad en neurología
12:00 PM-1:00 PM
Neurology Pictionary Bert Vargas MD, FAAN
Meet and Greet with the Pennsylvania Neurological Society Amtul Farheen MD, FAAN, Anthony May MD
Meet and Greet with the Pennsylvania Neurological Society Anthony May MD, William Jens DO, Elliott Schulman MD, FAAN, Brad Klein MD, MBA, FAAN, Amtul Farheen MD, FAAN, Parthasarathy Thirumala MD, FAAN, David Tabby DO, FAAN, Tara Morrison MD, FAAN, Jyoti Pillai MD, MBBS, MR, FAAN
1:00 PM-1:45 PM
Tip of the Iceberg: Ultra-high Cost Neurology Drugs Nicholas Johnson MD, FAAN
1:00 PM-2:15 PM
S1 - Neuroepidemiology
1:00 PM-3:00 PM
C60 - Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases Michael Geschwind MD, PhD, FAAN
C49 - Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease Ralph Jozefowicz MD, FAAN, Adam Quick MD
C50 - Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Johanna Fifi MD
C51 - Balance and Gait Disorders Alfonso Fasano MD, PhD
C52 - Introduction to Integrative Neurology Sarah Mulukutla MD, MPH
C53 - Introduction to Primary Headache Disorders: Migraine and Other Primary Headaches Including Tension-Type, Hypnic, Primary Stabbing and Nummular Headache Syndromes, Epicrania Fugax and Retinal Migraine Deborah Friedman MD, MPH, FAAN
C56 - Multiple Sclerosis Therapy: Disease-modifying Treatment I Scott Newsome DO, FAAN
C57 - Drugs and Toxin-induced Neurologic Emergencies Sara Hocker MD, FAAN
C58 - Business Strategies for Payer Negotiations and/or How to Go off the Grid Joseph Fritz PhD
C59 - Cuidados Neurocríticos (Neurocritical Care) Susana Bowling MD
C47 - Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies Amanda Peltier MD, MS
S2 - Neurocritical Care
S3 - Epilepsy/Clinical Neurophysiology (EEG) I
S5 - Therapeutics in ALS and SMA
S4 - Clinical Trials in Movement Disorders
S6 - MS and CNS Inflammatory Disease: Clinical Considerations I
1:00 PM-5:30 PM
C64 - Skills Workshop: Neurophysiologic Intraoperative Monitoring (Registration Required) Aatif Husain MD
1:30 PM-2:30 PM
AAN Leadership: Using Experiences to Answer the Tough Questions Ralph Sacco MD, MS, FAHA, FAAN, Sandra Olson MD, FAAN, Stanley Fahn MD, FAAN, Roger Rosenberg MD, FAAN, Robert Griggs MD, FAAN, Terrence Cascino MD, FAAN, Stephen Sergay MB BCh, FAAN, Francis Kittredge MD,FAAN
2:00 PM-2:30 PM
SIGN Faculty Advisor Conversation Yolanda Reyes-Iglesias MD
2:00 PM-2:45 PM
Teaching the Next Generation of Physician Advocates: Advocacy Curriculum for Neurology Residents Kara Stavros , Jonathan Cahill MD
3:00 PM-3:45 PM
Practice Innovation in Epilepsy Anup Patel MD, FAAN
Lost in Translation: Acknowledging and Respecting Cultural Differences With Your Patients Joseph Sirven MD, FAAN, Jose Merino MD, MPhil, FAAN
Education Research: The Secret Sauce to Career Advancement as Clinician Educator Andrew Southerland MD
3:30 PM-4:45 PM
S8 - Neuro Trauma and Sports Neurology
3:30 PM-5:30 PM
C76 - Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions Michael Geschwind MD, PhD, FAAN
C67 - Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology Ralph Jozefowicz MD, FAAN, Adam Quick MD
C68 - Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD
C70 - Introduction to Primary Headache Disorders: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches Christopher Boes MD, FAAN
C72 - Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease LynnMarie Trotti MD
C73 - Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
C74 - CNS Toxicities Neeraj Kumar MD
C75 - How to Run a Practice: Business Strategies for Neurology Private Practices and the Future David Evans MBA
C65 - Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Amanda Peltier MD, MS
N1 - Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN
S9 - Aging and Dementia: Clinical Trials and Novel Therapies
S10 - Biomarkers in Movement Disorders
4:00 PM-4:45 PM
Navigating Prior Authorizations Pearce Korb MD, FAAN
Living an Alpha Brain Wave Life: Work/Life Balance Tamika Burrus MD, FAAN
4:15 PM-5:00 PM
The Teenage Brain: Neuroscience You Can Use Frances Jensen MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
Remote and Team-based Care Jeffrey Buchhalter MD, FAAN, Raghav Govindarajan MD, FAAN, Anup Patel MD, FAAN, Calli Cook DNP, APRN, FNP-C
How to Be a Teacher as a Resident Jeremy Cutsforth-Gregory MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Cynthia Comella MD, FAAN

Monday, May 6, 2019
7:00 AM-7:30 AM
Tips to Sail Through the IRB Deborah Hall MD, PhD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-8:45 AM
Clerkship Administrators Certification Program Celia Linton
7:00 AM-9:00 AM
C78 - Young Onset and Atypical Alzheimer's Dementia Jonathan Graff-Radford MD
C80 - Epileptologists’ Secrets for the Busy General Neurologist: Localization, Imaging, and Fear of Surgery Carol Ulloa MD
C82 - Stroke in Young Adults and Women Aneesh Singhal MD, FAAN
C83 - Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN
C85 - Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD, MPH, FAAN
C86 - Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN
C87 - Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity (Registration Required) Allison Brashear MD, MBA, FAAN
7:30 AM-9:00 AM
Student Interest Group in Neurology (SIGN) Meeting Madhu Soni MD, FAAN
8:00 AM-8:45 AM
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease Ergun Uc MD
Personal Finances for Residents Brad Klein MD, MBA, FAAN
8:00 AM-9:00 AM
Updating the NIH BRAIN Initiative: A Dialogue with the AAN Walter Koroshetz MD, FAAN
8:30 AM-9:00 AM
Residency Program Director Conversation Rana Said MD, FAAN
9:15 AM-12:00 PM
Contemporary Clinical Issues Plenary Session Randolph Marshall MD, FAAN
11:30 AM-6:30 PM
P2 - Poster Session 2
11:45 AM-12:30 PM
Self-management in Neurologic Disease Lisa Shulman MD, FAAN, Barbara Jobst MD, FAAN
12:00 PM-12:45 PM
Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS) Program Bruce Ovbiagele MD, MSc, FAAN
LGBTQ+ Health in Neurology - Why It's Important and What You Need to Know Nicole Rosendale MD
12:00 PM-1:00 PM
Would You Fly With This Pilot? Joseph Sirven MD, FAAN
Meet a Member of Congress: U.S. Representative Brendan Boyle (D-PA) Brendan Boyle
1:00 PM-1:30 PM
Diversity Officer Roundtable Discussion Roy Hamilton MD, MS, FAAN
1:00 PM-1:45 PM
Controversies in Neuroimaging James Burke MD, James Johnston MD, JD
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Mona Hanna-Attisha, MD, MPH, FAAP Mona Hanna-Attisha MD, MPH, FAAP
1:00 PM-3:00 PM
C88 - Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
C101 - Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
C90 - Clinical Epilepsy I: Basics Tracey Milligan MD, FAAN
C91 - Neurology Update III: Headache, Neuro-otology, and Epilepsy Ralph Jozefowicz MD, FAAN, Adam Quick MD
C92 - Autism Spectrum Disorders What We Know and Where We Are Going Rujuta Wilson MD
C93 - Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
C96 - Everything You Need to Know to Practice Neuro-rehabilitation David Alexander MD
C95 - Concussion: Topics in Acute Concussion Nicole Reams MD
C97 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know Alison Pack MD
C99 - Starting a Practice From the Ground Up: A Guide for Early Career Neurologists Brad Klein MD, MBA, FAAN
C100 - Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders) Lilyana Amezcua MD, FAAN
N2 - Neuroscience in the Clinic: Interpretations of Genetic Results Massimo Pandolfo MD, FAAN, Karen Marder MD, MPH, FAAN
S12 - Progressive Multiple Sclerosis
S13 - Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
S15 - Intracerebral Hemorrhage and SAH
S16 - Huntington's Disease: From Bench to Clinical Trials
S17 - Headache: Clinical Trials I
1:00 PM-5:30 PM
C105 - Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia (Registration Required) Diego Torres-Russotto MD, FAAN
1:30 PM-2:30 PM
Blind Spots: The Impact of Conscious and Unconscious Biases Jeffrey McClean MD, FAAN, Charles Flippen MD, FAAN, Laraine Kaminsky
2:00 PM-2:45 PM
Using EHR to Close Referral Loops Melissa Yu MD, FAAN, Allison Weathers MD, FAAN, Allan Wu MD
A Career in Clinical Practice Stephen Sergay MB BCh, FAAN
2:00 PM-3:00 PM
ABPN Continuing Certification Information Session J. Clay Goodman MD, FAAN, A. Gordon Smith MD, FAAN
2:30 PM-3:15 PM
The Role of Integrative Medicine in Epilepsy Ann Marie Collier MD
2:45 PM-3:00 PM
Kenneth M. Viste, Jr., MD Patient Advocate of the Year Awards Glenn Graham MD, PhD, FAAN
2:45 PM-3:30 PM
Self Reflected: Deeply Fusing Art and Science to Create the World's Most Complex Artistic Depiction of the Human Brain Greg Dunn PhD
3:00 PM-3:45 PM
Research Outputs from the Axon Registry Lyell Jones MD, FAAN
Child Neurology for Trainees Rana Said MD, FAAN
3:30 PM-4:00 PM
Residency Program Director Conversation Emily Pharr MD
3:30 PM-4:45 PM
S18 - Autonomic Disorders
3:30 PM-5:30 PM
C113 - Concussion: Chronic Symptoms -- Selected Considerations for Why Your Patient May Not be Getting Better Michael Jaffee MD, FAAN
C120 - Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography Ruple Laughlin MD, FAAN
C106 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
C107 - Emergency Room Neuro-ophthalmology Heather Moss MD, PhD, FAAN
C108 - Clinical Epilepsy II: Considerations Across the Age Span: Pediatrics, Pregnancy, and Elderly Barbara Jobst MD, FAAN
C109 - Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies Ralph Jozefowicz MD, FAAN, Adam Quick MD
C112 - Myelopathies: Recognizing and Evaluating Myelopathic Patients for Inflammatory and Vascular Causes Benjamin Greenberg MD, FAAN
C115 - Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease John Hixson MD
C116 - LGBTQI Health in Neurology Holly Hinson MD, MCR, FAAN
C117 - Tourette Syndrome: Assessment and Management Tamara Pringsheim MD, FAAN
C118 - How to Understand and Incorporate Medical Cannabis into Clinical Practice Laszlo Mechtler MD, FAAN, FASN
C119 - Actualización en lesión cerebral traumática e ictus isquémico (Update: TBI and Stroke) Dario Beltran MD, FAAN, Jose Merino MD, MPhil, FAAN
S19 - Child Neurology: Updates in Autism, Migraine, MS, and Stroke
S20 - Headache Imaging and Physiology and Episodic Syndromes Associated with Migraine
S22 - Stroke Genetics, Cellular Responses, and Animal Models
S23 - Genetic Muscle Disorders
Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
3:45 PM-4:45 PM
Philadelphia: The City of Neurology Love Christopher Goetz MD, FAAN, Stephen Reich MD, FAAN, Frances Jensen MD, FAAN, Donald Silberberg MD,FAAN
4:00 PM-4:30 PM
Clerkship Director Conversation Holli Horak MD, FAAN
4:00 PM-4:45 PM
#MeanReviews: Flipping Imposter Syndrome on Its Head Rachel Marie Salas MD, FAAN
4:30 PM-5:00 PM
Everything You Wanted to Know About the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
Residency Program Director Conversation Erica Schuyler MD
Critical Care and Emergency Neurology Section Guided Poster Tour
5:00 PM-5:45 PM
Defining, Evaluating, and Promoting Healthy Cognitive Aging Kirk Daffner MD, FAAN
Safety and Quality Awards Amy Sanders MD, FAAN, Anup Patel MD, FAAN
Careers in Movement Disorders Stanley Fahn MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Kenneth Heilman MD, FAAN

Tuesday, May 7, 2019
7:00 AM-7:30 AM
Diversifying Your Funding Sources with NIH and Other Sources Ana-Claire Meyer MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Pursuing a Career in Industry Brandy Matthews MD, FAAN
7:00 AM-9:00 AM
C121 - Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
C123 - Child Neurology: Genetic and Metabolic Testing in Pediatric Epilepsy James Riviello MD
C122 - Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C124 - Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN
C127 - Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
C128 - Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy John Engstrom MD, FAAN
C129 - Critical Care Consultations for Neurohospitalists Vanja Douglas MD
C130 - Diagnostic Pearls in Myelitis: a Case-based Approach Eoin Flanagan MBBCh
7:30 AM-9:00 AM
C263 - Access: Strategies to Improve Access in Academic Medicine Jaya Trivedi MD, FAAN
8:00 AM-8:45 AM
Advocacy for Residents Kara Stavros
Welcome to NIH Day/Overview of NIH Funding with NINDS Director and NIA Director, Division of Neuroscience Walter Koroshetz MD, FAAN
9:15 AM-11:30 AM
Clinical Trials Plenary Session Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN
11:30 AM-6:30 PM
P3 - Poster Session 3
11:45 AM-12:45 PM
Emerging Science Session
12:00 PM-12:30 PM
Learn About Opportunities to Work with the NIH Intramural Program Avindra Nath MD, MBBS, FAAN
12:00 PM-12:45 PM
Optimizing Communication in Difficult Patient Relationships Veronica Santini MD, MA
12:00 PM-1:00 PM
Neuro Game Show: Localize the Lesion Luis Torres MD
12:30 PM-1:00 PM
NIH Grant Review Process Shanta Rajaram PhD
1:00 PM-1:45 PM
Women in Neurology: Thriving Through Challenges Divya Singhal MD, FAAN, Kathrin LaFaver MD, FAAN
K Awards and Training Programs – Planning for a Career as an NIH Investigator Nina Schor MD, PhD, FAAN
1:00 PM-3:00 PM
C132 - Frontotemporal Dementias Elizabeth Finger MD, FAAN
C131 - Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
C133 - Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) William Tatum DO, FAAN
C135 - Case Studies: Challenging Acute Ischemic Stroke Cases Vivien Lee MD, FAAN
C136 - Neuroimaging for the General Neurologist I: Brain Joshua Klein MD, PhD, FANA, FAAN, Ligia Onofrei MD
C137 - Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Michael Pourfar MD
C138 - Hot Topics in Headaches and Related Disorders I: Unusual Headaches, Childhood Headaches, and Concussion Management Amy Gelfand MD
C140 - Sports Neurology: Enhancing Athletic Performance Bert Vargas MD, FAAN
C141 - Rehabilitation in Neurology Marc Slutzky MD, PhD
C142 - Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS Stacey Clardy MD, PhD
N3 - Neuroscience in the Clinic: Stem Cells Antonio Omuro MD, Paul George MD, PhD, MSE
C144 - Actualización científica I (Scientific Update I - Spanish) Edgar Samaniego MD
S25 - Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
S26 - MS and CNS Inflammatory Disease: Clinical Considerations II
S27 - General Neurology: Improving Neurologic Care and the Impact of Therapeutics
C264 - Division Chief's Round Table: Maximizing Effectiveness and Addressing Challenges Claire Henchcliffe MD, PhD, FAAN
1:00 PM-5:30 PM
C148 - Skills Workshop: EMG: Basic (Registration Required) Holli Horak MD, FAAN
1:30 PM-2:30 PM
Neuro Exam Tricks and Tips Ludwig Gutmann MD, FAAN, Laurie Gutmann MD, FAAN, Nancy Newman MD, FAAN
1:45 PM-2:15 PM
NIH Funding and Professional Development Opportunities for Diverse Researchers Michelle Jones-London PhD
2:00 PM-2:45 PM
The HSR Game Show Gregory Esper MD, MBA, FAAN, Jason Sico MD, FAAN
A Career in Teleneurology: A Panel Discussion Eric Anderson MD, PhD
2:15 PM-3:00 PM
Clinical Trials and Networks – NeuroNEXT, StrokeNET, SIREN; Alzheimer’s Clinical Trials Consortium Clinton Wright MD, FAAN
3:00 PM-3:45 PM
The New Congress: How Will It Impact Neurology Nicholas Johnson MD, FAAN, James Goldenberg MD, FAAN
Live Intraoperative Monitoring Constantine Moschonas MD, FAAN
Oportunidades de colaboración internacional para realizar proyectos de investigación en enfermedades neurodegenerativas (Opportunities for International Collaborations to Conduct Research on Neurodegenerative Diseases) Yakeel Quiroz PhD
AD/ADRD Opportunities Clinton Wright MD, FAAN
3:30 PM-4:00 PM
Writing and Reviewing for the Neurology® Resident & Fellow Section John Millichap MD, FAAN
3:30 PM-5:30 PM
C150 - Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN
C151 - Lewy Body Dementias Karen Marder MD, MPH, FAAN
C164 - Update on Medical Management of Stroke Adam De Havenon MD
C154 - Neuroimaging for the General Neurologist II: Brain Joshua Klein MD, PhD, FANA, FAAN, Shamik Bhattacharyya MD
C155 - Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Leonard Verhagen Metman MD, PhD
C156 - Hot Topics in Headaches and Related Disorders II: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Andrew Charles MD
C157 - Evaluation and Treatment of Common Spine Disorders J. D. Bartleson MD, FAAN
C158 - Sports Concussion: Event Coverage Foundational Skills and Sport Specific Pearls Vernon Williams MD, FAAN
C160 - Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Eoin Flanagan MBBCh
C161 - Child Neurology: Metabolic Marc Patterson MD, FAAN, FRACP
C152 - Clinical Epilepsy IV: Surgery Gregory Cascino MD, FAAN
C163 - Creating a Roadmap for a Diverse Workforce in Academic Neurology Nimish Mohile MD, FAAN, Roy Hamilton MD, MS, FAAN
C162 - Coding 101: E&M, Basic Procedures, Non Face-to-Face, and New Codes Bruce Cohen MD, FAAN
C149 - Clinical Neurology for Advanced Practice Providers Jessica Erfan PA-C
S31 - MS and CNS Inflammatory Disease: Imaging
S32 - General Neurology: Advances in Neurology: From the Clinic to the Bench
IS2 - Invited Science: Movement Disorders Deborah Hall MD, PhD, FAAN
Presentation of the Sheila Essey Award: An Award for ALS Research
3:45 PM-4:30 PM
HEAL Initiative - Pain Research Funding Opportunities, Clinical and Basic Michael Oshinsky PhD
4:00 PM-4:45 PM
So You've Had an EHR for 10 Years, Now What? Allan Wu MD, Allison Weathers MD, FAAN, Melissa Yu MD, FAAN
Healthcare Disparities in Populations Alejandro Vargas MD, Sharon Lewis MD, Brett Kissela MD, FAAN, MS, Jeffrey McClean MD, FAAN
Not Dead Yet: How to Remain Relevant and Engaged in Mid to Late Career Heidi Schwarz MD, FAAN
4:30 PM-5:00 PM
Translational Research Amir Tamiz
Using the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
What Is the Neurologist Compensation and Productivity Survey and How Can It Increase My Value? David Evans MBA, Michael Markowski DO, FAAN
From Private Practice to Academics Sarah Benish MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Nancy Newman MD, FAAN

Wednesday, May 8, 2019
7:00 AM-7:30 AM
How to Write and Publish Research Papers, Reviews, and Other Scientific Communication Mark Hallett MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Simulation in Neurology Education Arielle Kurzweil MD, Ariane Lewis MD, Aaron Nelson MD
7:00 AM-9:00 AM
C165 - Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Robert Brown MD, FAAN
C166 - Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C167 - Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome Ligia Onofrei MD
C168 - Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
C169 - Neurological Intensive Care I: The Essentials David Greer MD, FAAN
C170 - Video EEG: Name That Spell Amy Crepeau MD
C171 - Child Neurology: Neuromuscular/Autoimmune Neurology Anne Connolly MD, FAAN
C172 - Advances in Neurogenetics Matthew Harms MD
C173 - Skills Workshop: Practical Training in Injection Techniques in the Treatment of Headache Disorders (Registration Required) Amaal Starling MD, Rashmi Halker Singh MD, FAAN
8:00 AM-8:30 AM
Recruiting Underrepresented Populations into Trials Temitayo Oyegbile MD, PhD
8:00 AM-8:45 AM
Complementary Therapies in Parkinson's Disease Veronica Santini MD, MA
Contract Negotiations for Residents Eva Ritzl MD, FAAN
Consejos prácticos para educadores médicos (Practical Advice for Medical Educators) Yazmin Odia MD, FAAN, MS
8:00 AM-9:00 AM
C265 - Using the Neurology Compensation and Productivity Survey in the Academic Setting J. Barnes MBA, Melissa Yu MD, FAAN
8:30 AM-9:00 AM
Neuroscience Course Director Conversation Madhu Soni MD, FAAN
9:15 AM-11:30 AM
Frontiers in Neuroscience Plenary Session Paul George MD, PhD, MSE
11:00 AM-11:30 AM
Resident and Fellow Conversation Abhimanyu Mahajan MD
11:30 AM-6:30 PM
P4 - Poster Session 4
11:45 AM-12:30 PM
Eating Your Way to Fewer Migraines Belinda Savage-Edwards MD, FAAN, Chef Tess Connor
12:00 PM-12:45 PM
Funding Clinically Oriented/Translational Research Before R01 – Consortium and Foundation Opportunities Aasef Shaikh MD
12:00 PM-1:00 PM
Neuro-Jeopardy: Telencephalon Twisters Laurice Yang MD, MHA, Veronica Santini MD, MA
1:00 PM-1:45 PM
Understanding the AAN's Latest Guidelines Tamara Pringsheim MD, FAAN
Headache Neuromodulation Therapy Heidi Schwarz MD, FAAN
Teaching Neurologic Competency Competently Despite the Competencies: A.B. Baker Award for Lifetime Achievement in Neurologic Education Keynote Address Steven Lewis MD, FAAN
1:00 PM-2:00 PM
S33 - Neuro-rehabilitation: Brain and Neuromuscular Recovery
Advancing Medicine: Inspiration and Innovation Featuring Patricia Churchland, PhD Patricia Churchland PhD
1:00 PM-3:00 PM
C175 - Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia Laura Tormoehlen MD, FAAN
C176 - Behavioral Neurology I: Network Anatomy of Behavior and Language Maria Gorno Tempini MD, PhD
C177 - Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach Maisha Robinson MD, MS
C179 - Nonmotor Manifestations of Parkinson's Disease I Jennifer Goldman MD, MS, FAAN
C187 - Comprehensive Migraine Update I: Migraine Diagnosis, Pathophysiology, and Comorbidities Gretchen Tietjen MD
C180 - Neurological Intensive Care II: Acute Brain and Spinal Cord Injury and Acute Neuromuscular Dysfunction Kristine O'Phelan MD
C181 - Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN
C182 - Neuroimaging for the General Neurologist: Spine J. D. Bartleson MD, FAAN, Felix Diehn MD
C184 - Business Efficiencies for Academic Neurology Departments: Business Strategies for Success Lyell Jones MD, FAAN, Gregory Esper MD, MBA, FAAN
C185 - Actualización en trastornos del movimiento (Update in Movement Disorders) Andres Deik Acosta Madiedo MD
N4 - Neuroscience in the Clinic: Immunotherapies in Neurological Disease Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN
S34 - Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
S35 - Stroke Prevention Strategies
S36 - Epilepsy/Clinical Neurophysiology (EEG) II
S37 - MS Biomarkers
S38 - Headache: Clinical Trials II
1:00 PM-5:30 PM
C190 - Skills Workshop: Neurostimulation (Registration Required) David Spencer MD, FAAN
C191 - Skills Workshop: Neuromuscular Ultrasound (Registration Required) Craig Zaidman MD
1:30 PM-2:30 PM
The Zoo Called - You Have a Consult Ann Tilton MD, FAAN
2:00 PM-2:45 PM
Being a Neurologist at a VA Hospital Jason Sico MD, FAAN
3:00 PM-3:45 PM
Foundations in Success in the AAN Holly Hinson MD, MCR, FAAN, Jeffrey McClean MD, FAAN, Ann Tilton MD, FAAN, Terrence Cascino MD, FAAN, Orly Avitzur MD, MBA, FAAN, Michael Markowski DO, FAAN, Christine Phelps
Understanding the AAN's Toolkit for Advanced Practice Providers Calli Cook DNP, APRN, FNP-C
How to Successfully Incorporate APPs into Your Practice James Stevens MD, FAAN
3:30 PM-5:30 PM
C192 - Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Laura Tormoehlen MD, FAAN
C193 - Behavioral Neurology II: Memory and Attention Maria Gorno Tempini MD, PhD
C195 - Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease Madhu Soni MD, FAAN
C194 - CANCELED Faculty
C196 - Nonmotor Manifestations of Parkinson's Disease II Jennifer Goldman MD, MS, FAAN
C203 - Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies Gretchen Tietjen MD
C197 - Neurological Intensive Care III: Vascular Diseases Lori Shutter MD, FCCM, FNCS
C198 - Integrating Sleep Medicine Concepts into Your Child Neurology Practice Suresh Kotagal MD, FAAN
C199 - Neuroimaging for the General Neurologist: Peripheral Nerve Kimberly Amrami MD, J. D. Bartleson MD, FAAN
C200 - Neurologic Case Studies in Pregnancy Amy Hessler DO, FAAN
C201 - Academic Neurology Departments 2020 and Beyond: Succeeding in the Tripartite Mission Lyell Jones MD, FAAN, Gregory Esper MD, MBA, FAAN
N5 - Neuroscience in the Clinic: Wearable Technology Deborah Hall MD, PhD, FAAN, Eric Klawiter MD, FAAN
S40 - Stroke Risk Factors and Epidemiology
S41 - Imaging in Movement Disorders
S42 - Neuromuscular Disorders
Presentation of the John Dystel Prize for Multiple Sclerosis Research
3:45 PM-4:15 PM
Update on the Complementary Therapies for MS: An Evidence-based Review Vijayshree Yadav MD, FAAN
4:00 PM-4:45 PM
Living Through a Ransomware Cyberattack: One Practice's Story, Insights, and Perspectives Leeann Garms
Choosing a Career in Neurocritical Care Katharina Busl MD, MS
4:15 PM-5:00 PM
Is There a Neurologist in the Stands? Glynnis Zieman MD, Javier Cardenas MD
4:45 PM-5:30 PM
Clinical Neurophysiology Section Guided Poster Tour
5:00 PM-5:45 PM
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit David Perez MD, Gaston Baslet MD, Aneeta Saxena MD
Succeeding in Small and Solo Practice Michael Wynn DO, FAAN, Erica Austin DO, Pooia Fattahi MD
Perspectivas profesionales para neurólogos en los Estados Unidos y América Latina (Professional Perspectives for Neurologists in the United States and Latin America) Ildefonso Rodriguez-Leyva MD, FAAN, Pedro Gonzalez-Alegre MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Vladimir Hachinski MD, DSc, FAAN

Thursday, May 9, 2019
7:00 AM-7:30 AM
So Your Paper Didn’t Get Accepted, Now What? Roy Strowd MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C205 - Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies David Herrmann MD, FAAN
C206 - Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
C207 - Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C208 - Contemporary Concerns About Brain Death Determination Ariane Lewis MD
C209 - Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease Irene Litvan MD, FAAN
C210 - Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management Kathleen Digre MD, FAAN
C212 - Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Wayne Grody MD, PhD
C214 - Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN
8:00 AM-8:30 AM
Neuroscience of Bias Jose Posas MD
8:00 AM-8:45 AM
A Migraine in Room 3: Patient-centered Care for Residents Paul Schanfield MD
9:15 AM-11:30 AM
Controversies in Neurology Plenary Session Aleksandar Videnovic MD, MSc, FAAN, Amy Brooks-Kayal MD, FAAN
11:30 AM-6:30 PM
11:45 AM-12:30 PM
How Your Social Life Might Be Helping (or Harming) Your Brain Joel Salinas MD
12:00 PM-12:45 PM
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time Nancy Isenberg MD, MPH, FAAN, Mary Rensel MD, FAAN
12:00 PM-1:00 PM
Who Wants to Be a Millionaire Jose Posas MD
1:00 PM-1:45 PM
Acupuncture Demonstration - 4 Gates Jennifer Bickel MD, FAAN
Are You My Mentor? Finding the Right Fit for Success in Research Holly Hinson MD, MCR, FAAN
Become an Advocacy Leader: When There's No Seat at the Table, Make Your Own Table! Nikesh Bajaj DO
1:00 PM-2:30 PM
Preview Film on Robin Williams’ Journey with LBD with His Wife Susan Schneider Williams
1:00 PM-3:00 PM
C215 - Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies Michelle Mauermann MD, FAAN
C216 - Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
C218 - Critical Care EEG Monitoring Suzette LaRoche MD, FAAN
C219 - Therapy in Neurology III: Epilepsy and Headache David Dodick MD, FAAN
C220 - Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia Joohi Jimenez Shahed MD
C226 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Jeffrey Gelfand MD, MAS, FAAN
C221 - Functional Neurologic Disorders I: Movement, Seizures, and Multiple Sclerosis Alberto Espay MD, FAAN
C222 - Good Neurology in Challenging Conditions: Lessons from Military Neurology Michele Gatheridge MD
C223 - United We Stand: Enhancing Your Practice with APPs Jessica Erfan PA-C
C224 - Burnout and Resilience: Strategies and Evidence for Enhancing Wellbeing Jennifer Molano MD, FAAN
C225 - Actualización científica II (Scientific Update II) Alejandro Tobon MD
S47 - Stroke Outcomes and Recurrence
S48 - Epilepsy/Clinical Neurophysiology (EEG) III
S49 - MS Epidemiology and Risk Stratification
1:00 PM-5:30 PM
C227 - Genomic Neurology: Developing Practical Knowledge of Tools and Concepts Through Case Studies Jeffery Vance MD, PhD
C228 - Skills Workshop: Brain Death: How to Perform a Brain Death Evaluation, Avoid Pitfalls and Convey the News to the Family (Registration Required) Panayiotis Varelas MD, PhD, FAAN
1:30 PM-2:30 PM
Rocky's Legacy: Historical Controversies of Boxing-related Concussions Anthony Alessi MD, FAAN, Barry Jordan MD, Tad Seifert MD
2:00 PM-2:45 PM
Innovative Ways to Decrease Wait Times in Your Practice Jason Sico MD, FAAN
3:00 PM-3:45 PM
How to Navigate the Demands of the First Years of Your Academic Career Nicholas Johnson MD, FAAN
3:00 PM-4:00 PM
Consejos prácticos para un buen examen neurológico (Neuro Exam Tips and Tricks) Jose Biller MD, FAAN, FACP, FAHA
3:30 PM-5:15 PM
S50 - Practice, Policy, and Ethics
3:30 PM-5:30 PM
C229 - Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives Mario Saporta MD, PhD, FAAN
C230 - Disparities in Care Charles Flippen MD, FAAN
C231 - Safe and Appropriate Opioid Prescribing in Neurology Adam Burkey MD
C232 - Women With Epilepsy (WWE): Beyond Seizure Control Anne Van Cott MD, FAAN
C233 - Therapy in Neurology IV: Movement Disorders and Stroke David Dodick MD, FAAN
C234 - Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics Shyamal Mehta MD, PhD
C236 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Jeffrey Gelfand MD, MAS, FAAN
C235 - Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
S51 - Child Neurology: Bench to Bedside: Progress in Treating Genetic Disorders
S52 - Acute Non-Interventional Stroke Care
S53 - Movement Disorders: Genetics and Clinical Features
S54 - Motor Neuron Disease
S55 - MS Basic Science
IS3 - Invited Science: Aging and Dementia Karen Marder MD, MPH, FAAN, Heather Snyder PhD
4:00 PM-4:30 PM
Resident and Fellow Conversation Christopher Perrone MD
4:00 PM-4:45 PM
Neurohospitalist Models of Care in an Academic Department: Opportunities and Challenges S. Josephson MD, FAAN
4:30 PM-5:30 PM
Standing on the Shoulders of Giants Stanley Fahn MD, FAAN
5:00 PM-5:30 PM
Division Chief Conversation Amy Brooks-Kayal MD, FAAN
5:00 PM-5:45 PM
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia Dean Sherzai MD, MAS, PhD, Ayesha Sherzai MD
Global Neurology: A Work in Progress Jerome Chin MD, PhD, MPH, FAAN
5:30 PM-6:00 PM
Division Chief Conversation Brenda Banwell MD, FAAN
7:00 PM-10:00 PM
C237 - Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease Robert Pascuzzi MD, FAAN
C238 - Case Studies in the ICU Katharina Busl MD, MS
C239 - Case Studies: Test Your Knowledge: A Case-based Approach to Neuroimaging Joshua Klein MD, PhD, FANA, FAAN
C240 - Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN
C241 - Case Studies: Challenging Headache Cases Kathleen Digre MD, FAAN
C242 - Case Studies: Dementia Gregory Day MD, MSc

Friday, May 10, 2019
7:00 AM-7:30 AM
Grant Writing 101: Getting Started Logan Schneider MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C243 - Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Michael Weiss MD, FAAN
C244 - Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases Matthew Hoerth MD
C245 - Controversies in Stroke Treatment and Prevention Pierre Fayad MD, FAAN, FAHA
C246 - Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
C247 - What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders Stephanie Nahas MD, FAAN
C248 - Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
C249 - Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems S. Josephson MD, FAAN
8:00 AM-8:30 AM
How to Put Together Effective Research Presentations Enrique Leira MD, MS, FAAN
9:15 AM-11:30 AM
Neurology Year in Review Plenary Session Martinson Arnan MD
11:30 AM-1:00 PM
P6 - Poster Session 6
11:45 AM-12:45 PM
Friday Grand Finale: Neuroimaging
12:00 PM-1:00 PM
The Neurology of Creativity at the Keyboard Phillip Pearl MD, FAAN
1:00 PM-1:45 PM
Growing Research in Medical Marijuana Anup Patel MD, FAAN
K is for Career Development: Tips on Successful Applications for NIH Career Development Awards Logan Schneider MD
1:00 PM-3:00 PM
C250 - Update in Epilepsy Joseph Sirven MD, FAAN
C252 - Update in Aging and Dementia Gil Rabinovici MD
C253 - Update in Movement Disorders Alfonso Fasano MD, PhD
S56 - MS Trials and Treatment
S57 - Acute Treatment and Imaging of Ischemic Stroke
S58 - Therapeutics in Neuromuscular Disorders
S59 - Migraine: Impact, Treatment Patterns and Resource Utilization
1:30 PM-2:15 PM
Movement Disorder Case Studies: What I Have Learned from My Patients Deborah Hall MD, PhD, FAAN, Susan Fox MD
2:00 PM-2:45 PM
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1 Nicholas Johnson MD, FAAN
Consensus-Based Care Recommendations for Adults with haha
2:45 PM-3:30 PM
Neuroanatomy of the Zombie Brain: A Year in Review Brian Hanrahan MD
3:00 PM-3:45 PM
Sleep: Why You Should Spend Your Career Helping People Do It Right Logan Schneider MD
The Quality Road Map: Linking Guidelines, Quality Measures, and Axon Registry to Improve Care for Your Patients Anup Patel MD, FAAN
3:30 PM-4:30 PM
C254 - Education Blitz: Child Neurology: Concussion Meeryo Choe MD
C255 - Education Blitz: Normal Pressure Hydrocephalus Neill Graff-Radford MD, FAAN
C257 - Education Blitz: Evolution of Autoimmune Neurology Steven Vernino MD, PhD, FAAN
C258 - Education Blitz: Multiple Sclerosis Stephen Krieger MD, FAAN
4:30 PM-5:30 PM
NeuroZone Bert Vargas MD, FAAN, Mark Milstein MD, FAAN, Jennifer Bickel MD, FAAN, Wayne Anderson MD, FAAN

Universal Navigation

P5 - Poster Session 5

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Footer